--12-310001643615Q1falsehttp://onterris.com/20260331#AccountingStandardsUpdate202505Member9P1Yhttp://fasb.org/us-gaap/2025#SecuredOvernightFinancingRateSofrMemberhttp://fasb.org/us-gaap/2025#SecuredOvernightFinancingRateSofrMemberhttp://fasb.org/us-gaap/2025#SecuredOvernightFinancingRateSofrMemberhttp://fasb.org/us-gaap/2025#BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1http://fasb.org/us-gaap/2025#BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1http://fasb.org/us-gaap/2025#BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1http://fasb.org/us-gaap/2025#BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1http://fasb.org/srt/2025#ChiefExecutiveOfficerMember0001643615us-gaap:RetainedEarningsMember2026-03-310001643615ont:DepreciationAndAmortizationMember2026-01-012026-03-310001643615ont:ConvertibleAndRedeemableSeriesATwoPreferredStockMember2025-03-310001643615us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberont:TwentyTwentyFiveCreditFacilityMemberont:PricingTier2Member2025-02-262025-02-260001643615us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2026-03-310001643615us-gaap:FairValueInputsLevel3Memberont:BusinessAcquisitionsContingentConsiderationLongTermMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001643615ont:TwoThousandSeventeenStockIncentivePlanMember2026-03-310001643615us-gaap:LeaseholdImprovementsMember2025-12-310001643615ont:TwoThousandAndTwentySixEarnOutsMemberont:EnvironmentalStandardsIncAndIndustrialAutomationGroupIncMember2026-01-012026-03-310001643615us-gaap:AdditionalPaidInCapitalMember2025-12-310001643615ont:TwentyTwentyFiveCreditFacilityMemberont:PricingTier2Member2025-02-262025-02-260001643615ont:TwentyTwentyFiveCreditFacilityMember2026-03-310001643615ont:ConvertibleAndRedeemableSeriesATwoPreferredStockMember2020-04-130001643615us-gaap:TreasuryStockCommonMember2026-03-310001643615us-gaap:InterestRateSwapMemberont:DebtInstrumentTwoMember2026-01-012026-03-310001643615us-gaap:ConstructionInProgressMember2026-03-310001643615us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2025-12-310001643615us-gaap:RetainedEarningsMember2025-03-310001643615us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeForwardMember2025-12-310001643615us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-03-310001643615us-gaap:InterestRateSwapMemberont:DebtInstrumentOneMember2026-03-310001643615us-gaap:AirTransportationEquipmentMember2025-12-310001643615us-gaap:PatentsMember2025-12-310001643615ont:MeasurementAndAnalysisMember2026-03-310001643615us-gaap:RevolvingCreditFacilityMemberont:TwentyTwentyFiveCreditFacilityMember2025-02-260001643615us-gaap:BuildingMember2025-12-310001643615country:US2025-12-310001643615ont:TwentyTwentyOneCreditFacilityMember2025-03-310001643615us-gaap:FairValueInputsLevel3Memberont:ConversionOptionRelatedToSeriesA2PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMember2026-01-012026-03-310001643615ont:TwoThousandSeventeenPlanMember2026-03-310001643615us-gaap:TreasuryStockCommonMember2026-01-012026-03-310001643615us-gaap:FairValueInputsLevel3Memberont:BusinessAcquisitionsContingentConsiderationLongTermMemberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001643615us-gaap:CommonStockMember2024-12-310001643615us-gaap:SellingGeneralAndAdministrativeExpensesMember2025-01-012025-03-310001643615ont:TwentyTwentyFiveCreditFacilityMember2024-07-010001643615us-gaap:BaseRateMemberont:PricingTier4Memberont:TwentyTwentyFiveCreditFacilityMember2025-02-262025-02-260001643615ont:OtherInternationalMember2025-12-310001643615us-gaap:RestrictedStockMemberont:TwoThousandSeventeenPlanMemberus-gaap:CostOfSalesMember2026-01-012026-03-310001643615ont:LoanAndAircraftSecurityAgreementMember2023-05-182023-05-180001643615us-gaap:RevolvingCreditFacilityMember2025-12-310001643615us-gaap:LeaseholdImprovementsMember2026-03-310001643615us-gaap:OperatingSegmentsMember2025-01-012025-03-310001643615ont:TwentyTwentyFiveCreditFacilityMember2026-01-012026-03-310001643615us-gaap:RestrictedStockMember2026-01-012026-03-3100016436152025-01-012025-12-310001643615us-gaap:InterestRateSwapMemberont:DebtInstrumentTwoMember2026-03-310001643615us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberont:PricingTier1Memberont:TwentyTwentyFiveCreditFacilityMember2025-02-262025-02-260001643615us-gaap:BaseRateMemberont:PricingTier1Memberont:TwentyTwentyFiveCreditFacilityMember2025-02-262025-02-260001643615ont:TwentyTwentyFiveCreditFacilityMember2025-03-310001643615ont:TwentyTwentyFiveCreditFacilityMember2025-02-262025-02-260001643615us-gaap:CommonStockMember2025-03-310001643615ont:ConvertibleAndRedeemableSeriesATwoPreferredStockMember2025-04-012025-04-010001643615ont:RestrictedStockUnitsAwardsMemberont:TwoThousandSeventeenPlanMember2024-12-310001643615us-gaap:InterestRateSwapMemberont:DebtInstrumentThreeMember2026-03-310001643615ont:TwentyTwentyOneCreditFacilityMember2026-03-310001643615us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2026-01-012026-03-310001643615us-gaap:CustomerRelationshipsMember2026-03-310001643615ont:TwoThousandSeventeenPlanMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2025-01-012025-03-310001643615us-gaap:FairValueInputsLevel3Memberont:BusinessAcquisitionsContingentConsiderationCurrentMemberus-gaap:FairValueMeasurementsRecurringMember2025-12-310001643615us-gaap:FairValueInputsLevel3Memberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2026-01-012026-03-310001643615us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberont:LoanAndAircraftSecurityAgreementMember2023-05-182023-05-180001643615us-gaap:NoncompeteAgreementsMember2026-03-310001643615ont:LoanAndAircraftSecurityAgreementMember2023-05-180001643615ont:ConsultingAndTreatmentMember2026-01-012026-03-3100016436152020-04-130001643615ont:SeriesATwoPreferredStockMember2025-01-012025-03-310001643615us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeForwardMember2026-01-012026-03-310001643615ont:TermLoanFacilityMember2025-12-310001643615ont:BusinessAcquisitionsContingentConsiderationCurrentMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2025-03-3100016436152026-05-010001643615us-gaap:EmployeeStockOptionMember2026-01-012026-03-310001643615ont:PricingTier5Memberont:TwentyTwentyFiveCreditFacilityMembersrt:MaximumMember2025-02-262025-02-260001643615us-gaap:RestrictedStockMemberont:TwoThousandSeventeenPlanMemberus-gaap:CostOfSalesMember2025-01-012025-03-310001643615ont:TwoThousandThirteenPlanMember2024-12-310001643615us-gaap:RetainedEarningsMember2024-12-310001643615us-gaap:FurnitureAndFixturesMember2026-03-310001643615us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-01-012026-03-310001643615us-gaap:CommonStockMember2026-03-310001643615us-gaap:BaseRateMemberont:PricingTier3Memberont:TwentyTwentyFiveCreditFacilityMember2025-02-262025-02-260001643615ont:PricingTier3Memberont:TwentyTwentyFiveCreditFacilityMembersrt:MaximumMember2025-02-262025-02-260001643615us-gaap:VehiclesMember2025-12-310001643615ont:AircraftLoanMember2026-03-310001643615us-gaap:OperatingSegmentsMemberont:ConsultingAndTreatmentMember2026-01-012026-03-310001643615us-gaap:InterestRateSwapMemberont:TwentyTwentyOneCreditFacilityMember2025-03-310001643615ont:IncrementalTermLoansMember2025-02-260001643615us-gaap:FairValueInputsLevel3Memberont:BusinessAcquisitionsContingentConsiderationLongTermMemberus-gaap:FairValueMeasurementsRecurringMember2025-12-310001643615ont:EquipmentLineOfCreditMember2026-03-310001643615us-gaap:RestrictedStockMember2025-01-012025-03-310001643615us-gaap:CommonStockMember2025-12-310001643615ont:RestrictedStockUnitsAwardsMemberont:TwoThousandSeventeenPlanMember2025-03-310001643615us-gaap:LandMember2026-03-310001643615us-gaap:ComputerSoftwareIntangibleAssetMember2026-03-3100016436152025-12-310001643615ont:TwentyTwentyFiveCreditFacilityMemberont:PricingTier5Member2025-02-262025-02-260001643615ont:InterestExpenseNetMember2026-01-012026-03-310001643615ont:TwoThousandSeventeenPlanMemberus-gaap:CostOfSalesMember2026-01-012026-03-310001643615us-gaap:RetainedEarningsMember2026-01-012026-03-310001643615ont:TwoThousandSeventeenPlanMember2024-12-310001643615srt:MinimumMemberont:TwentyTwentyFiveCreditFacilityMemberont:PricingTier2Member2025-02-262025-02-260001643615us-gaap:AirTransportationEquipmentMember2026-03-310001643615us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001643615ont:SignificantCustomerMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2025-01-012025-03-310001643615us-gaap:EmployeeStockOptionMemberont:TwoThousandSeventeenPlanMemberus-gaap:CostOfSalesMember2026-01-012026-03-310001643615us-gaap:EmployeeStockOptionMemberont:TwoThousandSeventeenPlanMember2025-01-012025-03-310001643615ont:RestrictedStockUnitsAwardsMemberont:TwoThousandSeventeenPlanMember2025-01-012025-03-310001643615ont:TwoThousandThirteenPlanMember2025-03-310001643615us-gaap:EmployeeStockOptionMember2025-01-012025-03-3100016436152025-05-060001643615ont:TwoThousandThirteenPlanMember2025-01-012025-03-310001643615us-gaap:RetainedEarningsMember2025-12-310001643615ont:ConvertibleAndRedeemableSeriesATwoPreferredStockMember2025-07-012025-07-010001643615us-gaap:OfficeEquipmentMember2026-01-012026-03-310001643615us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberont:PricingTier5Memberont:TwentyTwentyFiveCreditFacilityMember2025-02-262025-02-260001643615us-gaap:TradeNamesMember2025-12-310001643615us-gaap:RevolvingCreditFacilityMember2026-03-310001643615ont:RestrictedStockUnitsAwardsMemberont:TwoThousandSeventeenPlanMember2026-01-012026-03-310001643615us-gaap:ConstructionInProgressMember2025-12-310001643615ont:BusinessAcquisitionsContingentConsiderationCurrentMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2026-01-012026-03-310001643615us-gaap:NoncompeteAgreementsMember2025-12-310001643615ont:InterestExpenseNetMember2025-01-012025-03-310001643615ont:SignificantCustomerMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2025-01-012025-12-310001643615us-gaap:CommonStockMember2026-01-012026-03-310001643615srt:MinimumMemberont:PricingTier3Memberont:TwentyTwentyFiveCreditFacilityMember2025-02-262025-02-260001643615us-gaap:FairValueInputsLevel3Memberont:ConversionOptionRelatedToSeriesA2PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001643615ont:MeasurementAndAnalysisMember2026-01-012026-03-310001643615us-gaap:RevolvingCreditFacilityMemberont:TwentyTwentyFiveCreditFacilityMemberus-gaap:LetterOfCreditMember2025-02-260001643615us-gaap:RestrictedStockMemberont:TwoThousandSeventeenPlanMember2025-01-012025-03-310001643615us-gaap:EquipmentMember2025-12-310001643615country:CA2026-03-310001643615ont:TwoThousandSeventeenPlanMemberus-gaap:CostOfSalesMember2025-01-012025-03-310001643615us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001643615us-gaap:FairValueInputsLevel3Memberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2026-03-310001643615ont:SignificantCustomerMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2026-01-012026-03-3100016436152025-03-310001643615ont:TwoThousandSeventeenPlanMember2025-01-310001643615ont:ConvertibleAndRedeemableSeriesATwoPreferredStockMember2025-01-012025-03-310001643615us-gaap:VehiclesMember2026-03-310001643615srt:MaximumMember2026-01-012026-03-310001643615us-gaap:OperatingSegmentsMemberont:MeasurementAndAnalysisMember2025-01-012025-03-310001643615ont:TwentyTwentyFiveRevolvingCreditFacilityMember2026-03-310001643615us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310001643615srt:MinimumMember2026-01-012026-03-310001643615ont:TwoThousandThirteenPlanMember2025-01-012025-12-310001643615ont:ConsultingAndTreatmentMember2026-03-310001643615ont:LabAndTestEquipmentMember2025-12-310001643615us-gaap:FairValueInputsLevel3Memberont:BusinessAcquisitionsContingentConsiderationLongTermMemberus-gaap:FairValueMeasurementsRecurringMember2026-03-310001643615ont:TwentyTwentyFiveCreditFacilityMember2025-02-260001643615us-gaap:BaseRateMemberont:TwentyTwentyFiveCreditFacilityMemberont:PricingTier2Member2025-02-262025-02-260001643615us-gaap:OperatingSegmentsMember2026-01-012026-03-310001643615country:US2026-01-012026-03-310001643615us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeForwardMember2026-03-310001643615us-gaap:FairValueInputsLevel3Memberont:BusinessAcquisitionsContingentConsiderationLongTermMemberus-gaap:FairValueMeasurementsRecurringMember2025-01-012025-03-310001643615ont:TwoThousandSeventeenPlanMember2024-01-012024-12-310001643615ont:TwoThousandSeventeenPlanMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2026-01-012026-03-310001643615ont:AircraftLoanMember2025-12-310001643615country:CA2026-01-012026-03-310001643615us-gaap:PatentsMember2026-03-310001643615ont:OtherInternationalMember2026-01-012026-03-310001643615ont:TwoThousandSeventeenPlanMember2026-01-310001643615us-gaap:OperatingSegmentsMemberont:ConsultingAndTreatmentMember2025-01-012025-03-310001643615us-gaap:AdditionalPaidInCapitalMember2024-12-310001643615ont:PricingTier4Memberont:TwentyTwentyFiveCreditFacilityMembersrt:MaximumMember2025-02-262025-02-2600016436152026-03-3100016436152025-01-012025-03-310001643615us-gaap:CommonStockMember2025-01-012025-03-310001643615us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310001643615country:US2026-03-310001643615ont:PricingTier3Memberont:TwentyTwentyFiveCreditFacilityMember2025-02-262025-02-260001643615country:US2025-01-012025-03-310001643615country:CA2025-12-310001643615ont:TwentyTwentyFiveCreditFacilityTermLoanMember2026-03-310001643615ont:ConvertibleAndRedeemableSeriesATwoPreferredStockMember2024-12-310001643615ont:TwoThousandSeventeenPlanMember2026-01-012026-03-310001643615ont:TwoThousandThirteenPlanMember2026-01-012026-03-310001643615ont:TwentyTwentyOneCreditFacilityMember2026-01-012026-03-310001643615ont:TwoThousandThirteenPlanMember2025-12-310001643615us-gaap:SellingGeneralAndAdministrativeExpensesMember2026-01-012026-03-310001643615us-gaap:RestrictedStockMemberont:TwoThousandSeventeenPlanMember2026-01-012026-03-310001643615ont:TwentyTwentyFiveCreditFacilityMemberont:TermLoanFacilityMember2025-02-260001643615ont:PriorCreditFacilityMemberont:TermLoanFacilityMember2026-01-012026-03-310001643615us-gaap:OtherNonoperatingIncomeExpenseMemberont:ConvertibleAndRedeemableSeriesATwoPreferredStockMember2025-01-012025-03-310001643615us-gaap:FairValueInputsLevel3Memberont:BusinessAcquisitionsContingentConsiderationLongTermMemberus-gaap:FairValueMeasurementsRecurringMember2026-01-012026-03-310001643615ont:TermLoanFacilityMember2026-03-310001643615ont:DepreciationAndAmortizationMember2025-01-012025-03-310001643615us-gaap:FairValueInputsLevel3Memberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001643615us-gaap:FairValueInputsLevel3Memberont:BusinessAcquisitionsContingentConsiderationCurrentMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001643615us-gaap:EmployeeStockOptionMemberont:TwoThousandSeventeenPlanMemberus-gaap:CostOfSalesMember2025-01-012025-03-310001643615us-gaap:LandMember2025-12-310001643615ont:SeriesATwoPreferredStockMember2026-01-012026-03-310001643615ont:SignificantCustomerMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2026-01-012026-03-310001643615us-gaap:FairValueInputsLevel3Memberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2025-01-012025-03-310001643615us-gaap:AdditionalPaidInCapitalMember2026-01-012026-03-310001643615ont:TwoThousandSeventeenPlanMember2025-03-310001643615ont:RestrictedStockUnitsAwardsMemberont:TwoThousandSeventeenPlanMember2025-12-310001643615us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberont:PricingTier4Memberont:TwentyTwentyFiveCreditFacilityMember2025-02-262025-02-260001643615us-gaap:AdditionalPaidInCapitalMember2026-03-310001643615us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-12-310001643615us-gaap:InterestRateSwapMemberont:TwentyTwentyFiveCreditFacilityMember2026-03-310001643615us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310001643615us-gaap:OperatingSegmentsMemberont:MeasurementAndAnalysisMember2026-01-012026-03-310001643615us-gaap:InterestRateSwapMemberont:DebtInstrumentOneMember2026-01-012026-03-3100016436152027-04-012026-03-310001643615ont:TwoThousandThirteenStockIncentivePlanMember2025-03-310001643615ont:ConsultingAndTreatmentMember2025-12-310001643615us-gaap:ComputerSoftwareIntangibleAssetMember2025-12-310001643615ont:ConvertibleAndRedeemableSeriesATwoPreferredStockMember2025-07-010001643615ont:TwoThousandAndTwentySixEarnOutsMemberont:EnvironmentalStandardsIncAndIndustrialAutomationGroupIncMember2026-03-3100016436152020-04-132020-04-130001643615ont:RestrictedStockUnitsAwardsMemberont:TwoThousandSeventeenPlanMember2026-03-310001643615us-gaap:FurnitureAndFixturesMember2025-12-310001643615us-gaap:BuildingMember2026-03-3100016436152026-01-012026-03-310001643615ont:TwentyTwentyFiveCreditFacilityMember2025-01-012025-03-310001643615us-gaap:FairValueInputsLevel3Memberont:BusinessAcquisitionsContingentConsiderationCurrentMemberus-gaap:FairValueMeasurementsRecurringMember2025-01-012025-03-310001643615ont:MeasurementAndAnalysisMember2025-12-310001643615us-gaap:InterestRateSwapMemberont:DebtInstrumentThreeMember2026-01-012026-03-310001643615us-gaap:EquipmentMember2026-03-310001643615ont:TwoThousandSeventeenPlanMember2025-01-012025-12-310001643615us-gaap:RestrictedStockMemberont:TwoThousandSeventeenPlanMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2025-01-012025-03-310001643615ont:PricingTier4Memberont:TwentyTwentyFiveCreditFacilityMember2025-02-262025-02-260001643615ont:PriorCreditFacilityMember2025-02-260001643615ont:TwoThousandSeventeenPlanMember2025-12-310001643615ont:PricingTier1Membersrt:MinimumMemberont:TwentyTwentyFiveCreditFacilityMember2025-02-262025-02-260001643615us-gaap:EmployeeStockOptionMemberont:TwoThousandSeventeenPlanMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2026-01-012026-03-310001643615us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberont:PricingTier3Memberont:TwentyTwentyFiveCreditFacilityMember2025-02-262025-02-260001643615ont:AircraftLoanMember2026-03-310001643615us-gaap:RestrictedStockMemberont:TwoThousandSeventeenPlanMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2026-01-012026-03-310001643615us-gaap:RetainedEarningsMember2025-01-012025-03-310001643615srt:MinimumMemberont:PricingTier4Memberont:TwentyTwentyFiveCreditFacilityMember2025-02-262025-02-260001643615us-gaap:BaseRateMemberont:TwentyTwentyFiveCreditFacilityMemberont:PricingTier5Member2025-02-262025-02-260001643615ont:TwentyTwentyFiveCreditFacilityMembersrt:MaximumMemberont:PricingTier2Member2025-02-262025-02-260001643615ont:BusinessAcquisitionsContingentConsiderationCurrentMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2026-03-310001643615us-gaap:CustomerRelationshipsMember2025-12-310001643615ont:TwoThousandThirteenStockIncentivePlanMember2026-03-310001643615ont:LabAndTestEquipmentMember2026-03-310001643615ont:TwentyTwentyFiveCreditFacilityMember2025-01-012025-12-310001643615country:CA2025-01-012025-03-310001643615ont:TwoThousandThirteenPlanMember2026-03-3100016436152024-12-310001643615us-gaap:FairValueInputsLevel3Memberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2025-12-310001643615ont:OtherInternationalMember2026-03-310001643615us-gaap:TradeNamesMember2026-03-310001643615us-gaap:FairValueInputsLevel3Memberont:ConversionOptionRelatedToSeriesA2PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMember2026-03-310001643615us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2025-01-012025-03-310001643615us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-310001643615ont:TwoThousandSeventeenStockIncentivePlanMember2025-03-310001643615us-gaap:EmployeeStockOptionMemberont:TwoThousandSeventeenPlanMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2025-01-012025-03-310001643615us-gaap:FairValueInputsLevel3Memberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001643615us-gaap:FairValueInputsLevel3Memberont:ConversionOptionRelatedToSeriesA2PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001643615ont:TwoThousandSeventeenPlanMember2025-01-012025-03-3100016436152026-04-012026-03-310001643615us-gaap:AdditionalPaidInCapitalMember2025-03-310001643615ont:PricingTier1Memberont:TwentyTwentyFiveCreditFacilityMember2025-02-262025-02-260001643615ont:OtherInternationalMember2025-01-012025-03-310001643615us-gaap:FairValueInputsLevel3Memberont:ConversionOptionRelatedToSeriesA2PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMember2025-01-012025-03-310001643615us-gaap:EmployeeStockOptionMemberont:TwoThousandSeventeenPlanMember2026-01-012026-03-310001643615ont:TwoThousandThirteenPlanMember2024-01-012024-12-31iso4217:USDxbrli:sharesont:Officexbrli:pureont:Employeexbrli:sharesont:OperatingUnitont:Segmentiso4217:USDont:Customer

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 10-Q

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2026

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 001-39394

 

Onterris, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

 

Delaware

46-4195044

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer
Identification No.)

5120 Northshore Drive,

North Little Rock, Arkansas

72118

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (501) 900-6400

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange on which registered

Common Stock, par value $0.000004 per share

 

ONT

 

The New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

Accelerated filer

 

 

 

 

Non-accelerated filer

Smaller reporting company

 

 

 

 

 

 

 

Emerging growth company

 

 

 

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

As of May 1, 2026, the registrant had 36,139,227 shares of common stock, $0.000004 par value per share, outstanding.

 

 


 

Table of Contents

 

Page

PART I.

FINANCIAL INFORMATION

Item 1.

Financial Statements

1

Unaudited Condensed Consolidated Statements of Financial Position

1

Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss

2

Unaudited Condensed Consolidated Statements of Convertible and Redeemable Series A-2 Preferred Stock and Stockholders’ Equity

3

 

Unaudited Condensed Consolidated Statements of Cash Flows

4

Notes to Unaudited Condensed Consolidated Financial Statements

6

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

24

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

32

Item 4.

Controls and Procedures

32

 

 

 

PART II.

OTHER INFORMATION

 

Item 1.

Legal Proceedings

34

Item 1A.

Risk Factors

34

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

34

Item 3.

Defaults Upon Senior Securities

34

Item 4.

Mine Safety Disclosures

34

Item 5.

Other Information

34

Item 6.

Exhibits

35

Signatures

36

 

i


 

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements.

ONTERRIS, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

(In thousands, except share data)

 

 

March 31,

 

 

December 31,

 

 

 

2026

 

 

2025

 

Assets

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

Cash, cash equivalents and restricted cash

 

$

10,046

 

 

$

11,223

 

Accounts receivable, net

 

 

117,613

 

 

 

155,380

 

Contract assets

 

 

65,799

 

 

 

58,831

 

Prepaid and other current assets

 

 

23,186

 

 

 

14,959

 

           Total current assets

 

 

216,644

 

 

 

240,393

 

Non-current assets

 

 

 

 

 

 

Property and equipment, net

 

 

66,059

 

 

 

63,853

 

Operating lease right-of-use asset, net

 

 

35,086

 

 

 

36,560

 

Finance lease right-of-use asset, net

 

 

34,670

 

 

 

37,595

 

Goodwill

 

 

466,563

 

 

 

466,786

 

Other intangible assets, net

 

 

119,763

 

 

 

126,383

 

Other assets

 

 

9,238

 

 

 

9,726

 

Total assets

 

$

948,023

 

 

$

981,296

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

Accounts payable and other accrued liabilities

 

$

56,595

 

 

$

71,778

 

Accrued payroll and benefits

 

 

25,749

 

 

 

52,773

 

Business acquisitions contingent consideration, current

 

 

6,942

 

 

 

14,883

 

Current portion of operating lease liabilities

 

 

10,622

 

 

 

10,735

 

Current portion of finance lease liabilities

 

 

6,472

 

 

 

6,602

 

Current portion of long-term debt

 

 

11,251

 

 

 

11,230

 

           Total current liabilities

 

 

117,631

 

 

 

168,001

 

Non-current liabilities

 

 

 

 

 

 

Business acquisitions contingent consideration, long-term

 

 

1,858

 

 

 

2,755

 

Other non-current liabilities

 

 

6,424

 

 

 

7,088

 

Deferred tax liabilities, net

 

 

21,861

 

 

 

21,817

 

Operating lease liability, net of current portion

 

 

26,865

 

 

 

28,215

 

Finance lease liability, net of current portion

 

 

23,154

 

 

 

25,180

 

Long-term debt, net of deferred financing fees

 

 

310,139

 

 

 

277,065

 

           Total liabilities

 

$

507,932

 

 

$

530,121

 

Commitments and contingencies

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

 

Common stock, $0.000004 par value; authorized shares: 190,000,000 at March 31, 2026 and December 31, 2025; issued shares: 36,516,149 and 35,929,665 at March 31, 2026 and December 31, 2025, respectively; outstanding shares: 36,139,836 and 35,929,665 at March 31, 2026 and December 31, 2025, respectively

 

 

 

 

 

 

Additional paid-in-capital

 

 

739,425

 

 

 

727,927

 

Accumulated deficit

 

 

(286,203

)

 

 

(273,513

)

Accumulated other comprehensive loss

 

 

(3,132

)

 

 

(3,239

)

Treasury stock, at cost; 376,313 and 0 shares at March 31, 2026 and December 31, 2025, respectively

 

 

(9,999

)

 

 

 

Total stockholders’ equity

 

 

440,091

 

 

 

451,175

 

Total liabilities and Stockholders’ Equity

 

$

948,023

 

 

$

981,296

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

1


 

ONTERRIS, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND

COMPREHENSIVE LOSS

(In thousands, except per share data)

 

 

Three Months Ended March 31,

 

 

 

2026

 

 

2025

 

Revenues

 

$

168,518

 

 

$

177,834

 

Cost of revenues (exclusive of depreciation and amortization shown below)

 

 

101,468

 

 

 

108,406

 

Selling, general and administrative expense

 

 

61,322

 

 

 

66,232

 

Fair value changes in business acquisition contingencies

 

 

(838

)

 

 

477

 

Depreciation and amortization

 

 

12,629

 

 

 

13,294

 

Loss from operations

 

 

(6,063

)

 

 

(10,575

)

Other income (expense), net

 

 

1,142

 

 

 

(848

)

Interest expense, net

 

 

(5,466

)

 

 

(5,065

)

Total other income (expense), net

 

 

(4,324

)

 

 

(5,913

)

Loss before expense from income taxes

 

 

(10,387

)

 

 

(16,488

)

Income tax expense

 

 

2,303

 

 

 

2,871

 

Net loss

 

$

(12,690

)

 

$

(19,359

)

 

 

 

 

 

 

 

Equity adjustment from foreign currency translation

 

 

107

 

 

 

(353

)

Comprehensive loss

 

 

(12,583

)

 

 

(19,712

)

 

 

 

 

 

 

 

Weighted average common shares outstanding

 

 

 

 

 

 

  Basic

 

 

36,045

 

 

 

34,502

 

  Diluted

 

 

36,045

 

 

 

34,502

 

Net loss per share attributable to common stockholders

 

 

 

 

 

 

  Basic

 

$

(0.35

)

 

$

(0.64

)

  Diluted

 

$

(0.35

)

 

$

(0.64

)

Net loss attributable to common stockholders

 

 

 

 

 

 

Net loss

 

$

(12,690

)

 

$

(19,359

)

Convertible and redeemable series A-2 preferred stock dividend

 

 

 

 

 

(2,750

)

Net loss attributable to common stockholders

 

$

(12,690

)

 

$

(22,109

)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

2


 

ONTERRIS, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE AND REDEEMABLE SERIES A-2 PREFERRED STOCK AND STOCKHOLDERS’ EQUITY

(In thousands, except share data)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

Convertible and Redeemable

 

 

 

 

 

 

 

 

 

Additional

 

 

 

Other

 

Total

 

 

 

Series A-2 Preferred Stock

 

Common Stock

 

Treasury Stock

 

Paid-In

 

Accumulated

 

Comprehensive

 

Stockholders'

 

 

 

Shares

 

Amount

 

Shares

 

Amount

 

Shares

 

Amount

 

Capital

 

Deficit

 

Loss

 

Equity

 

Balance at December 31, 2024

 

 

11,667

 

 

92,928

 

 

34,309,778

 

 

 

 

 

 

 

 

721,067

 

 

(272,670

)

 

(2,133

)

 

446,264

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(19,359

)

 

 

 

(19,359

)

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

13,723

 

 

 

 

 

 

13,723

 

Dividend payment to the Series A-2 preferred stockholders

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(2,750

)

 

 

 

 

 

(2,750

)

Common stock issuances pursuant to exercises and vesting of equity awards

 

 

 

 

 

 

473,974

 

 

 

 

 

 

 

 

61

 

 

 

 

 

 

61

 

Acquisitions contingent consideration paid in common stock

 

 

 

 

 

 

323,834

 

 

 

 

 

 

 

 

6,558

 

 

 

 

 

 

6,558

 

Accumulated other comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(353

)

 

(353

)

Balance at March 31, 2025

 

 

11,667

 

$

92,928

 

 

35,107,586

 

$

 

 

 

$

 

$

738,659

 

$

(292,029

)

$

(2,486

)

$

444,144

 

Balance at December 31, 2025

 

 

 

 

 

 

35,929,665

 

 

 

 

 

 

 

 

727,927

 

 

(273,513

)

 

(3,239

)

 

451,175

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(12,690

)

 

 

 

(12,690

)

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

9,073

 

 

 

 

 

 

9,073

 

Common stock issuances pursuant to exercises and vesting of equity awards

 

 

 

 

 

 

586,484

 

 

 

 

 

 

 

 

2,425

 

 

 

 

 

 

2,425

 

Common stock repurchased under stock repurchase program

 

 

 

 

 

 

 

 

 

 

(376,313

)

 

(9,999

)

 

 

 

 

 

 

 

(9,999

)

Accumulated other comprehensive income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

107

 

 

107

 

Balance at March 31, 2026

 

 

 

$

 

 

36,516,149

 

$

 

 

(376,313

)

$

(9,999

)

$

739,425

 

$

(286,203

)

$

(3,132

)

$

440,091

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

3


 

ONTERRIS, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

 

 

For the Three Months Ended March 31,

 

 

 

2026

 

 

2025

 

Operating activities:

 

 

 

 

 

 

Net loss

 

$

(12,690

)

 

$

(19,359

)

Adjustments to reconcile net loss to net cash (used in) provided by operating activities:

 

 

 

 

 

 

Provision (recovery) for credit loss

 

 

(612

)

 

 

407

 

Depreciation and amortization

 

 

12,629

 

 

 

13,294

 

Non-cash leases expense

 

 

2,870

 

 

 

3,085

 

Stock-based compensation expense

 

 

9,073

 

 

 

13,723

 

Fair value changes in financial instruments

 

 

(1,131

)

 

 

308

 

Write off of deferred financing costs

 

 

 

 

 

908

 

Deferred income taxes

 

 

(1,710

)

 

 

4,174

 

Other operating activities, net

 

 

(887

)

 

 

1,354

 

Changes in operating assets and liabilities, net of acquisitions:

 

 

 

 

 

 

Accounts receivable and contract assets

 

 

32,527

 

 

 

10,358

 

Prepaid expenses and other current assets

 

 

(6,519

)

 

 

(5,473

)

Accounts payable and other accrued liabilities

 

 

(15,672

)

 

 

(5,637

)

Accrued payroll and benefits

 

 

(27,024

)

 

 

(8,622

)

Change in operating leases

 

 

(2,923

)

 

 

(3,016

)

Other assets

 

 

432

 

 

 

 

Net cash (used in) provided by operating activities

 

$

(11,637

)

 

$

5,504

 

Investing activities:

 

 

 

 

 

 

Purchases of property and equipment

 

 

(5,667

)

 

 

(3,154

)

Purchase price true ups

 

 

 

 

 

(562

)

Proceeds from other activities

 

 

142

 

 

 

11

 

Net cash used in investing activities

 

$

(5,525

)

 

$

(3,705

)

Financing activities:

 

 

 

 

 

 

Proceeds from revolving line of credit

 

 

140,400

 

 

 

106,945

 

Repayment of the revolving line of credit

 

 

(104,258

)

 

 

(97,246

)

Repayment of aircraft loan

 

 

(300

)

 

 

(280

)

Proceeds from term loan

 

 

 

 

 

200,000

 

Repayment of term loan

 

 

(2,500

)

 

 

(189,219

)

Payment of contingent consideration and other purchase price true ups

 

 

(8,000

)

 

 

(297

)

Repayment of finance leases

 

 

(1,826

)

 

 

(1,563

)

Payments of deferred financing costs

 

 

 

 

 

(2,189

)

Proceeds from issuance of common stock for exercised stock options

 

 

2,425

 

 

 

61

 

Proceeds from building sale leaseback

 

 

 

 

 

2,500

 

Dividend payment to the series A-2 stockholders

 

 

 

 

 

(2,750

)

Repurchases of common stock

 

 

(9,999

)

 

 

 

Net cash provided by financing activities

 

$

15,942

 

 

$

15,962

 

Change in cash, cash equivalents and restricted cash

 

 

(1,220

)

 

 

17,761

 

Foreign exchange impact on cash balance

 

 

43

 

 

 

(420

)

Cash, cash equivalents and restricted cash:

 

 

 

 

 

 

Beginning of year

 

 

11,223

 

 

 

12,935

 

End of period

 

$

10,046

 

 

$

30,276

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

4


 

 

 

For the Three Months Ended March 31,

 

 

 

2026

 

 

2025

 

Supplemental disclosures of cash flows information:

 

 

 

 

 

 

Cash paid for interest

 

$

4,839

 

 

$

3,874

 

Cash paid for income taxes, net

 

$

138

 

 

$

930

 

Supplemental disclosures of non-cash investing and financing activities:

 

 

 

 

 

 

Accrued purchases of property and equipment

 

$

40

 

 

$

156

 

Property and equipment purchased under finance leases

 

$

817

 

 

$

2,779

 

Acquisitions unpaid contingent consideration

 

$

8,800

 

 

$

26,700

 

Acquisitions contingent consideration paid in common stock

 

$

 

 

$

6,558

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

5


 

ONTERRIS, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except where otherwise indicated)

1. DESCRIPTION OF THE BUSINESS AND BASIS OF PRESENTATION

Description of the Business

Onterris, Inc. (“Onterris” or the “Company”), formerly known as Montrose Environmental Group, Inc., is a corporation formed in November 2013, under the laws of the State of Delaware. The Company changed its name to Onterris on April 17, 2026. The Company has approximately 120 offices across the United States, Canada, and Australia and approximately 3,500 employees as of March 31, 2026.

Onterris is an environmental services company serving the recurring environmental needs of a diverse client base, including Fortune 500 companies and federal, state and local governments. Historically, the Company had three reportable segments: Assessment, Permitting and Response, Measurement and Analysis, and Remediation and Reuse. Effective in the first quarter of 2026, the Company realigned its reportable segments to reflect updates made to its organizational structure and operating model. As a result of these changes, the Company aggregated the Assessment, Permitting and Response and Remediation and Reuse segments into a newly created Consulting and Treatment segment based on their similar characteristics, including similar long-term financial performance, the nature of services provided, internal processes for delivering those services, and types of customers. The Company's Measurement and Analysis and corporate segments were not affected by the realignment. See Note 19 – Segment Information for more details.

Consulting and Treatment segment provides environmental consulting, engineering, and implementation services to help clients assess, manage, and mitigate environmental risks across the lifecycle of their operations and projects. The Company supports environmental assessments, regulatory permitting, toxicology consulting, emergency preparedness, and response and environmental audits and permits, while also delivering engineering, design, and implementation solutions to treat contaminated water and remediate soil. The Company works closely with clients to navigate regulatory requirements, address environmental liabilities, respond to operational disruptions, and develop practical, sustainable solutions for new industrial developments, facility upgrades and ongoing operations. The Company provides these services as a consultant and service provider and does not own the properties, facilities, or underlying environmental liabilities associated with client projects.

Measurement and Analysis segment is one of the largest providers of environmental testing and laboratory services in North America. The Company's highly credentialed teams test and analyze air, water and soil to determine concentrations of contaminants, as well as the toxicological impact of contaminants on flora, fauna and human health. The Company's offerings include source and ambient air testing and monitoring, leak detection, and advanced multi-media laboratory services, including air, soil, stormwater, wastewater and drinking water analysis.

Corporate activities not directly related to segment performance, including general corporate expenses, interest and taxes, are reported separately.

Prior period information has been recast herein to reflect the above change in segment reporting. The recast segment information constitutes a reclassification and has no impact on reported net income (loss) or earnings (loss) per share for preceding periods. This change does not restate information previously reported in the consolidated statements of financial position, the consolidated statements of operations and comprehensive income (loss), consolidated statements of convertible and redeemable series A-2 preferred stock and stockholders’ equity or consolidated statements of cash flows for the Company for preceding periods.

Basis of Presentation

The unaudited condensed consolidated financial statements include the operations of the Company and its wholly-owned subsidiaries. These unaudited condensed consolidated financial statements are presented in conformity with accounting principles generally accepted in the United States (U.S. GAAP) and have been prepared pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC) that permit reduced disclosure for interim periods. The unaudited condensed consolidated financial statements include all accounts of the Company and, in the opinion of management, include all recurring adjustments and normal accruals necessary for a fair statement of the Company’s financial position, results of operations and cash flows for the dates and periods presented. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited financial statements as of and for the year ended December 31, 2025. Results for interim periods are not necessarily indicative of the results to be expected during the remainder of the current year or for any future period. All intercompany transactions, accounts and profits, have been eliminated in the unaudited condensed consolidated financial statements.

Certain prior period amounts, which are not material, have been reclassified to conform to current period presentation in the notes to the condensed consolidated financial statements. The realigned segment information does not modify or update the disclosures included in the Company's Annual Report on Form 10-K for the year ended December 31, 2025 in any way, nor does it reflect any subsequent information or events, other than as required to reflect the change in segments as described above.

6


 

2. SUMMARY OF NEW ACCOUNTING PRONOUNCEMENTS

Recently Adopted Accounting Pronouncements

ASU 2025-05 —In July 2025, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2025-05, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets (ASU 2025-05), which introduced a practical expedient when estimating expected credit losses for current accounts receivable and current contract assets arising from transactions accounted for under Topic 606. ASU 2025-05 is effective for the Company's fiscal years beginning after December 15, 2025, and interim periods within those fiscal years. The Company adopted the standard and elected the practical expedient on January 1, 2026. The adoption of the standard did not have a material impact on the Company's consolidated financial statements.

Recently Issued Accounting Pronouncements Not Yet Adopted

ASU 2024-03 —In November 2024, the FASB issued ASU 2024-03, Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (ASU 2024-03), which is intended to improve the disclosures about a public business entity’s expenses and address requests from investors for more detailed information about the types of expenses in commonly presented expense captions (such as cost of sales; selling, general, and administrative expenses; and research and development). ASU 2024-03 is effective for the Company's fiscal year beginning January 1, 2027, and interim periods within fiscal years beginning after December 15, 2027, and allows the use of a prospective or retrospective approach. The Company plans to adopt the standard on January 1, 2027, and is currently evaluating the impact of the adoption of the standard on its consolidated financial statements.

ASU 2025-06 —In September 2025, the FASB issued ASU 2025-06, Intangibles — Goodwill and Other — Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software (ASU 2025-06), which removes all references to software development project stages, making the guidance neutral to different software development methodologies. Under the ASU, software capitalization will begin when management has authorized and committed to funding the software project and it is probable that the project will be completed and the software will be used as intended. ASU 2025-06 is effective for the Company's fiscal year beginning January 1, 2028, and interim periods within fiscal years beginning after December 15, 2027, and allows the use of a prospective, modified transition, or retrospective approach. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of the standard on its consolidated financial statements.

3. REVENUES AND ACCOUNTS RECEIVABLE

The Company’s main revenue sources derive from the following revenue streams:

Consulting and Treatment Revenues are generated from multidisciplinary environmental consulting services, and engineering, design, implementation and operating and maintenance (O&M) services primarily to treat contaminated water and remove contaminants from soil. The majority of the contracts are fixed-fee or time-and-material based.

Measurement and Analysis Revenues are generated from emissions sampling, testing and reporting services, leak detection services, ambient air monitoring services and laboratory testing services. The majority of the contracts are fixed-fee or time-and-materials based.

Disaggregation of Revenue—The Company disaggregates revenue by its operating segments and geographic location. The Company believes disaggregating revenue into these categories achieves the disclosure objectives to depict how the nature, amount, and uncertainty of revenue and cash flows are affected by economic factors. Disaggregated revenue disclosures are provided in Note 19.

Contract Balances—The Company presents contract balances for unbilled receivables (contract assets), as well as customer advances, and deposits and deferred revenue (contract liabilities) within contract assets and accounts payable and other accrued expenses, respectively, on the unaudited condensed consolidated statements of financial position. Amounts are generally billed at periodic intervals (e.g. weekly, bi-weekly or monthly) as work progresses in accordance with agreed-upon contractual terms. The Company utilizes the practical expedient to not adjust the promised amount of consideration for the effects of a significant financing component for arrangements in which the period between when the Company transfers services to a customer and when the customer pays for those services is one year or less. Amounts recorded as unbilled receivables generally arise when billing occurs subsequent to revenue recognition, for example for services the Company is not contractually entitled to bill based on the passage of time. The Company sometimes receives advances or deposits from customers before revenue is recognized, resulting in contract liabilities.

The following table presents the Company’s contract balances:

 

 

March 31,

 

 

December 31,

 

 

 

2026

 

 

2025

 

Contract assets

 

$

65,799

 

 

$

58,831

 

Contract liabilities

 

 

10,424

 

 

 

14,996

 

 

7


 

Revenue recognized during the three months ended March 31, 2026, included in the contract liabilities balance at the beginning of the year was $5.7 million. The revenue recognized from the contract liabilities consisted of the Company satisfying performance obligations during the normal course of business.

Remaining Unsatisfied Performance Obligations—Remaining unsatisfied performance obligations represent the total dollar value of work to be performed on cost to cost contracts awarded and in progress. The amount of remaining unsatisfied performance obligations increases with new contracts or additions to existing contracts and decreases as revenue is recognized on existing contracts. Contracts are included in the amount of remaining unsatisfied performance obligations when an enforceable agreement has been reached. As of March 31, 2026 and December 31, 2025, the estimated revenue expected to be recognized in the future related to performance obligations that are unsatisfied was approximately $49.7 million and $68.4 million, respectively. As of March 31, 2026, the Company expected to recognize approximately $40.2 million of this amount as revenue within one year and $9.5 million the year after.

Accounts Receivable, Net—The Company extends non-interest-bearing trade credit to its customers in the ordinary course of business. Accounts receivable, net consisted of the following:

 

 

March 31, 2026

 

 

December 31, 2025

 

Accounts receivable, invoiced

 

$

125,369

 

 

$

163,694

 

Allowance for credit losses

 

 

(7,756

)

 

 

(8,314

)

   Accounts receivable, net

 

$

117,613

 

 

$

155,380

 

The Company had no customers that exceeded 10.0% of its gross receivables as of March 31, 2026 and one as of December 31, 2025. For the three months ended March 31, 2026, the Company had one customer who accounted for more than 10.0% of revenue. For the three months ended March 31, 2025 the Company had no customers who accounted for more than 10.0% of revenue.

The Company performs ongoing credit evaluations and based on past collection experience, the Company believes that the receivable balance from its largest customer does not represent a significant credit risk.

From time to time, the Company may sell certain accounts receivable to a financial institution on a non-recourse basis for cash, less a discount at a rate that approximates the interest rate on the Company's senior secured credit facility. The Company has no retained interests in the sold receivables and only performs collection and administrative functions for the purchaser. The Company accounts for these receivable transfers as sales under ASC 860, Transfers and Servicing. During the three months ended March 31, 2026 and 2025 the Company did not sell any accounts receivable.

The allowance for credit losses consisted of the following:

 

 

Beginning
Balance

 

 

Bad Debt
Expense (Recovery)

 

 

Charged to
Allowance

 

 

Ending
Balance

 

Three months ended March 31, 2026

 

$

8,314

 

 

$

(612

)

 

$

54

 

 

$

7,756

 

Year ended December 31, 2025

 

 

2,093

 

 

 

6,713

 

 

 

(492

)

 

 

8,314

 

 

4. PREPAID AND OTHER CURRENT ASSETS

Prepaid and other current assets consisted of the following:

 

 

March 31, 2026

 

 

December 31, 2025

 

Deposits

 

$

1,001

 

 

$

967

 

Prepaid expenses

 

 

19,628

 

 

 

11,367

 

Supplies

 

 

2,557

 

 

 

2,625

 

Prepaid and other current assets

 

$

23,186

 

 

$

14,959

 

 

8


 

5. PROPERTY AND EQUIPMENT, NET

Property and equipment, net, consisted of the following:

 

 

March 31, 2026

 

 

December 31, 2025

 

Lab and test equipment

 

$

24,772

 

 

$

24,604

 

Vehicles

 

 

6,706

 

 

 

6,696

 

Equipment

 

 

72,907

 

 

 

70,702

 

Furniture and fixtures

 

 

5,325

 

 

 

5,322

 

Leasehold improvements

 

 

15,360

 

 

 

15,335

 

Aircraft

 

 

12,386

 

 

 

12,386

 

Building

 

 

5,764

 

 

 

5,764

 

 

 

143,220

 

 

 

140,809

 

Land

 

 

1,089

 

 

 

1,089

 

Construction in progress

 

 

5,026

 

 

 

1,930

 

Less: Accumulated depreciation

 

 

(83,276

)

 

 

(79,975

)

   Total property and equipment—net

 

$

66,059

 

 

$

63,853

 

Total depreciation expense included in the unaudited condensed consolidated statements of operations was $3.4 million for the three months ended March 31, 2026 and $3.2 million for the three months ended March 31, 2025.

6. LEASES

Leases are classified as either finance leases or operating leases based on criteria in Accounting Standard Codification (ASC) 842. The Company has finance leases for its vehicle and equipment leases and operating leases for its real estate space and office equipment leases. The Company’s operating and finance leases generally have original lease terms between 1 year and 15 years, and in some instances include one or more options to renew. The Company includes options to extend the lease term in the initial measurement of leases if the options are reasonably certain of being exercised. The Company currently considers some of its renewal options to be reasonably certain to be exercised. Some leases also include early termination options, which can be exercised under specific conditions. The Company does not have material residual value guarantees or restrictive covenants associated with its leases.

Finance and operating lease right-of-use (ROU) assets represent the right to use an underlying asset for the lease term, and finance and operating lease liabilities represent the obligation to make lease payments arising from the lease.

The Company calculates the present value of its finance and operating leases using an estimated incremental borrowing rate (IBR), which requires judgment. For real estate operating leases, the Company estimates the IBR based on prevailing market rates for collateralized debt in a similar economic environment with similar payment terms and maturity dates commensurate with the terms of the lease. For all other leases, the Company estimates the IBR based on the stated interest rate on the contract. Since many of the inputs used to calculate the rate implicit in the leases are not readily determinable from the lessee’s perspective, the Company does not use the implicit interest rate.

Certain leases contain variable payments, these payments are expensed as incurred and not included in the Company’s operating lease ROU assets and operating lease liabilities. These amounts primarily include payments for maintenance, utilities, taxes, and insurance and are excluded from the present value of the Company’s lease obligations.

The Company does not record operating lease ROU assets or operating lease liabilities for leases with an initial term of 12 months or less. The Company also combines lease and non-lease components on all new or modified operating leases into a single lease component for all classes of assets.

When a lease is terminated before the expiration of the lease term, irrespective of whether the lease is classified as a finance lease or an operating lease, the lessee would derecognize the ROU asset and corresponding lease liability. Any difference would be recognized as a gain or

9


 

loss related to the termination of the lease. Similarly, if a lessee is required to make any payments or receives any consideration when terminating the lease, it would include such amounts in the determination of the gain or loss upon termination.

Equipment Line of Credit—The Company has an equipment line of credit, specifically dedicated for the purchases of allowable equipment and related freight, installation costs and taxes paid. As of March 31, 2026, the outstanding balance was $15.0 million on this credit line. Interest on leases financed under this facility is fixed and based on the SOFR swap rate on or closest to the closing date. As of March 31, 2026 equipment leased through this line of credit met the finance lease criteria as per ASC 842 and accordingly is accounted for as finance lease ROU assets and finance lease liabilities.

The components of lease expense were as follows:

 

 

 

For the Three Months Ended March 31,

 

 

Statement of Operations Location

 

2026

 

 

2025

 

Operating lease cost

 

 

 

 

 

 

 

Lease cost

Selling, general and administrative expense

 

$

3,148

 

 

$

3,137

 

Variable lease cost

Selling, general and administrative expense

 

 

799

 

 

 

799

 

Total operating lease cost

 

 

$

3,947

 

 

$

3,936

 

 

 

 

 

 

 

 

Finance lease cost

 

 

 

 

 

 

 

Amortization of ROU assets

Depreciation and amortization

 

$

2,580

 

 

$

1,751

 

Interest on lease liabilities

Interest expense, net

 

 

583

 

 

 

259

 

Total finance lease cost

 

 

$

3,163

 

 

$

2,010

 

Total lease cost

 

 

$

7,110

 

 

$

5,946

 

Supplemental cash flows information related to leases was as follows:

 

 

For the Three Months Ended March 31,

 

 

 

2026

 

 

2025

 

Cash paid for amounts included in the measurement of lease liabilities:

 

 

 

 

 

 

Operating cash flows used in operating leases

 

$

3,390

 

 

$

3,416

 

Operating cash flows used for interest related to finance leases

 

 

583

 

 

 

259

 

Financing cash flows used in finance leases

 

 

1,617

 

 

 

1,304

 

 

 

 

 

 

 

 

Lease liabilities arising from new ROU assets:

 

 

 

 

 

 

Operating leases

 

 

1,538

 

 

 

2,347

 

Finance leases

 

 

241

 

 

 

2,511

 

Weighted average remaining lease terms and weighted average discount rates were:

 

 

March 31, 2026

 

 

 

Operating Leases

 

 

Finance Leases

 

Weighted average remaining lease term (years)

 

 

4.8

 

 

 

9.6

 

Weighted average discount rate

 

 

5.1

%

 

 

6.7

%

 

 

 

 

 

 

 

 

 

March 31, 2025

 

 

 

Operating Leases

 

 

Finance Leases

 

Weighted average remaining lease term (years)

 

 

4.4

 

 

 

3.6

 

Weighted average discount rate

 

 

5.0

%

 

 

6.6

%

 

10


 

The following is a schedule by year of the maturities of lease liabilities with original terms in excess of one year:

 

Operating Leases

 

 

Finance Leases

 

Remainder of 2026

 

$

9,484

 

 

$

6,376

 

2027

 

 

10,078

 

 

 

7,099

 

2028

 

 

8,272

 

 

 

5,360

 

2029

 

 

6,316

 

 

 

3,701

 

2030

 

 

3,010

 

 

 

1,889

 

2031 and thereafter

 

 

6,032

 

 

 

17,760

 

Total undiscounted future minimum lease payments

 

$

43,192

 

 

$

42,185

 

Less imputed interest

 

 

(5,705

)

 

 

(12,559

)

Total discounted future minimum lease payments

 

$

37,487

 

 

$

29,626

 

 

7. BUSINESS ACQUISITIONS

During the three months ended March 31, 2026 and 2025, the Company did not complete any business acquisitions; however, strategic acquisitions remain a core part of the Company's growth strategy.

The Company may be required to make up to $9.6 million in aggregate earn-out payments between the years 2026 and 2027 in connection with certain of its business acquisitions, of which up to $5.1 million may be paid only in cash, up to $2.8 million may be paid only in common stock and up to $1.7 million may be paid, at the Company’s option, in cash or common stock.

Transaction costs related to previous business combinations totaled $0.1 million for the three months ended March 31, 2026 and $0.7 million for the three months ended March 31, 2025. These costs are expensed within selling, general and administrative expense in the accompanying unaudited condensed consolidated statements of operations.

 

8. GOODWILL AND INTANGIBLE ASSETS

The Company tests each of its reporting units for goodwill impairment annually on October 1, or upon a triggering event, in accordance with ASC Topic 350, “Intangibles –Goodwill and Other.” Effective in the first quarter of 2026, the Company reorganized its business into two reportable segments as discussed in Note 19 – Segment Information. This changed the composition of the Company's reporting units which resulted in the combination of historical goodwill from the Assessment, Permitting and Response and Remediation and Reuse segments to its newly created Consulting and Treatment segment. Additionally, the change in composition of the Company's reporting units was considered a triggering event requiring an interim goodwill impairment test as of March 31, 2026. The Company determined that no impairment existed as the estimated fair values of its reporting units were in excess of their respective carrying values, both before and after the reorganization. Amounts related to goodwill are as follows:

 

 

Consulting and Treatment

 

 

Measurement and Analysis

 

 

Total

 

Balance as of December 31, 2025

 

$

347,706

 

 

$

119,080

 

 

$

466,786

 

Foreign currency translation adjustments

 

 

 

 

 

(223

)

 

 

(223

)

Balance as of March 31, 2026

 

$

347,706

 

 

$

118,857

 

 

$

466,563

 

 

11


 

Amounts related to finite-lived intangible assets are as follows:

March 31, 2026

 

Gross Balance

 

 

Accumulated Amortization

 

 

Total Intangible Assets—Net

 

Customer relationships

 

$

264,477

 

 

$

165,396

 

 

$

99,081

 

Covenants not to compete

 

 

41,417

 

 

 

36,843

 

 

 

4,574

 

Trade names

 

 

25,886

 

 

 

25,595

 

 

 

291

 

Proprietary software

 

 

32,007

 

 

 

26,522

 

 

 

5,485

 

Patent

 

 

17,479

 

 

 

7,147

 

 

 

10,332

 

Total other intangible assets, net

 

$

381,266

 

 

$

261,503

 

 

$

119,763

 

 

 

 

 

 

 

 

 

 

 

December 31, 2025

 

Gross Balance

 

 

Accumulated Amortization

 

 

Total Intangible Assets—Net

 

Customer relationships

 

$

264,564

 

 

$

160,459

 

 

$

104,105

 

Covenants not to compete

 

 

41,418

 

 

 

36,293

 

 

 

5,125

 

Trade names

 

 

25,917

 

 

 

25,441

 

 

 

476

 

Proprietary software

 

 

31,982

 

 

 

25,912

 

 

 

6,070

 

Patent

 

 

17,479

 

 

 

6,872

 

 

 

10,607

 

Total other intangible assets, net

 

$

381,360

 

 

$

254,977

 

 

$

126,383

 

Intangible assets with finite lives are stated at cost, less accumulated amortization and impairment losses, if any. These intangible assets are amortized using the straight-line method over the estimated useful lives of the assets.

Amortization expense was $6.7 million three months ended March 31, 2026 and $8.4 million for the three months ended March 31, 2025.

Future amortization expense is estimated to be as follows for each of the five following years and thereafter:

December 31,

 

 

 

2026 (remaining)

 

$

18,014

 

2027

 

 

24,289

 

2028

 

 

19,198

 

2029

 

 

13,480

 

2030

 

 

8,985

 

Thereafter

 

 

35,797

 

Total

 

$

119,763

 

 

9. ACCOUNTS PAYABLE AND OTHER ACCRUED LIABILITIES

Accounts payable and other accrued liabilities consisted of the following:

 

 

March 31, 2026

 

 

December 31, 2025

 

Accounts payable

 

$

26,441

 

 

$

34,806

 

Accrued expenses

 

 

15,340

 

 

 

18,373

 

Contract liabilities

 

 

10,424

 

 

 

14,996

 

Other current liabilities

 

 

4,390

 

 

 

3,603

 

Total accounts payable and other accrued liabilities

 

$

56,595

 

 

$

71,778

 

 

12


 

10. ACCRUED PAYROLL AND BENEFITS

Accrued payroll and benefits consisted of the following:

 

 

March 31, 2026

 

 

December 31, 2025

 

Accrued payroll

 

$

13,222

 

 

$

13,501

 

Accrued bonuses

 

 

6,003

 

 

 

28,568

 

Accrued paid time off

 

 

3,361

 

 

 

3,603

 

Accrued medical

 

 

807

 

 

 

2,305

 

Accrued other

 

 

2,356

 

 

 

4,796

 

Total accrued payroll and benefits

 

$

25,749

 

 

$

52,773

 

 

11. INCOME TAXES

The Company calculates its interim income tax provision in accordance with ASC Topic 270, Interim Reporting (ASC 270), and ASC 740, Income Taxes. The Company’s effective tax rate (ETR) from continuing operations was (22.2)% for the three months ended March 31, 2026 and (17.4)% for the three months ended March 31, 2025. Income tax expense recorded by the Company during the three months ended March 31, 2026 and 2025 was $2.3 million and $2.9 million, respectively. The difference between the ETR and federal statutory rate of 21.0% is primarily attributable to the impact of tax-deductible goodwill, recognition of a U.S. federal and state valuation allowance and state and foreign income tax provisions.

A valuation allowance is recorded when it is more-likely-than-not that some of the Company’s deferred tax assets may not be realized. Significant judgment is applied when assessing the need for a valuation allowance and the Company considers future taxable income, reversals of existing deferred tax assets and liabilities and ongoing prudent and feasible tax planning strategies, in making such assessment. As of March 31, 2026, the Company’s U.S. federal, state and various foreign net deferred tax assets are not more-likely-than-not to be realized and a full valuation allowance is maintained with respect to such jurisdictions.

The Company records uncertain tax positions in accordance with ASC 740, on the basis of a two-step process in which (i) the Company determines whether it is more likely than not a tax position will be sustained on the basis of the technical merits of such position and (ii) for those tax positions meeting the more-likely-than-not recognition threshold, the Company would recognize the largest amount of tax benefit that is more than 50.0% likely to be realized upon ultimate settlement with the related tax authority. As of March 31, 2026, the Company had uncertain tax positions of $0.6 million. The Company classifies interest and penalties recognized on uncertain tax positions as a component of income tax expense.

The One Big Beautiful Bill Act ("OBBB Act") was enacted on July 4, 2025, in the United States. The OBBB Act includes several significant provisions, including re-establishing a 100% bonus depreciation deduction, re-establishing rules in calculating business interest expense limitations pursuant to Internal Revenue Code §163(j), changing the calculation of international tax inclusions, and removing the capitalization requirements for domestic research or experimental (R&E) expenditures paid or incurred in tax years beginning after December 31, 2024.

12. DEBT

Debt consisted of the following:

 

 

March 31, 2026

 

 

December 31, 2025

 

Term loan facility

 

$

195,000

 

 

$

197,500

 

Revolving line of credit

 

 

120,441

 

 

 

84,663

 

Aircraft loan

 

 

7,825

 

 

 

8,125

 

Less deferred debt issuance costs

 

 

(1,876

)

 

 

(1,993

)

Total debt

 

$

321,390

 

 

$

288,295

 

Less current portion of long-term debt

 

 

(11,251

)

 

 

(11,230

)

Long-term debt, less current portion

 

$

310,139

 

 

$

277,065

 

Deferred Financing Costs—Costs relating to debt issuance have been deferred and are presented as netted against the underlying debt balance. These costs are amortized to interest expense over the terms of the underlying debt instruments. The amortization of deferred debt issuance cost to interest expense was $0.1 million and $1.1 million for the three months ended March 31, 2026 and 2025, respectively.

2025 Credit FacilityOn February 26, 2025, the Company entered into an Amended and Restated Senior Secured Credit Agreement providing for a $500.0 million credit facility comprised of a $200.0 million term loan and a $300.0 million revolving line of credit (2025 Credit

13


 

Facility). The revolving line of credit under the 2025 Credit Facility includes a $20.0 million sublimit for the issuances of letters of credit. Subject to certain exceptions, all amounts under the 2025 Credit Facility will become due on February 26, 2030. The Company has the option to borrow incremental term loans, or request an increase in aggregate commitments under the revolving line of credit up to an aggregate amount of $200.0 million, subject to the satisfaction of certain conditions.

The Company used proceeds from the 2025 Credit Facility to repay in full its prior senior secured credit facility originally entered into in 2021. The resulting write-off of the remaining unamortized debt issuance costs from the prior credit facility amounted to $0.9 million. Total loss on debt extinguishments was recorded in interest expense, net within the consolidated statements of operations for the three months ended March 31, 2025.

The 2025 Credit Facility term loan must be repaid in quarterly installments and amortizes at a rate of 1.25% per quarter beginning December 31, 2025 through December 31, 2029, with final payment and amortization on February 26, 2030.

The 2025 Credit Facility term loan and the revolving line of credit bear interest subject to the applicable spread based on the Company’s leverage ratio and benchmark spread as follows:

Pricing Tier

 

Consolidated
Leverage Ratio

 

Senior Credit Facilities
Benchmark Spread

 

 

Senior Credit Facilities
Base Rate Spread

 

 

Commitment
Fee

 

 

Letter of Credit Fee

 

 

1

 

3.75x to 1.0

 

 

2.50

 

%

 

1.50

 

%

 

0.25

 

%

 

2.50

 

%

2

 

< 3.75x to 1.0 but ≥ 3.25 to 1.0

 

 

2.25

 

 

 

1.25

 

 

 

0.23

 

 

 

2.25

 

 

3

 

<3.25x to 1.0 but ≥ 2.50 to 1.0

 

 

2.00

 

 

 

1.00

 

 

 

0.20

 

 

 

2.00

 

 

4

 

<2.50x to 1.0 but ≥ 1.75 to 1.0

 

 

1.75

 

 

 

0.75

 

 

 

0.15

 

 

 

1.75

 

 

5

 

<1.75x to 1.0

 

 

1.50

 

 

 

0.50

 

 

0.15

 

 

 

1.50

 

 

The 2025 Credit Facility includes a number of covenants imposing certain restrictions on the Company’s business, including, among other things, restrictions on the Company’s ability, subject to certain exceptions and baskets, to incur indebtedness, incur liens on its assets, agree to any additional negative pledges, pay dividends or repurchase stock, limit the ability of its subsidiaries to pay dividends or distribute assets, make investments, enter into any transaction of merger or consolidation, liquidate, wind-up or dissolve, or convey any part of its business, assets or property, or acquire the business, property or assets of another person, enter into sale and leaseback transactions, enter into certain transactions with affiliates, engage in any material line of business substantially different from those engaged on the closing date, modify the terms of indebtedness subordinated to the loans incurred under the 2025 Credit Facility and modify the terms of its organizational documents. The 2025 Credit Facility permits certain restricted payments, including common stock repurchases, subject to a maximum pro-forma leverage ratio of 3.00 times, and minimum pro-forma fixed charge coverage ratio of 1.25 times and no event of default. The 2025 Credit Facility also includes financial covenants which require the Company to remain below a maximum total net leverage ratio of 4.00 through the fiscal quarter ending March 31, 2026, stepping down to 3.75 times thereafter, and a minimum fixed charge coverage ratio of 1.25 times.

The Company deferred $2.2 million of debt issuance costs related to the 2025 Credit Facility in the first quarter of 2025. Quarterly installment repayments for the term loan under the 2025 Credit Facility commenced in the fourth quarter of 2025. For the three months ended March 31, 2026, quarterly term loan installment repayments under the 2025 Credit Facility were $2.5 million.

As of March 31, 2026 and December 31, 2025, the Company’s consolidated total leverage ratio (as defined in the 2025 Credit Facility) was 2.8 times and 2.5 times, respectively, and the Company was in compliance with all covenants under the 2025 Credit Facility.

The 2025 Credit Facility requires customary mandatory prepayments of the term loan and revolving line of credit and cash collateralization of letters of credit, subject to customary exceptions, including 100.0% of the proceeds of debt not permitted by the 2025 Credit Facility, 100.0% of the proceeds of certain dispositions, subject to customary reinvestment rights, where applicable, and 100.0% of insurance or condemnation proceeds, subject to customary reinvestment rights, where applicable. The 2025 Credit Facility also includes customary events of default and related acceleration and termination rights.

The weighted average interest rate for the three months ended March 31, 2026, before giving effect to the impact of the interest rate swaps, was 5.7% and after giving effect to the impact of the interest rate swaps, was 5.6%. The weighted average interest rate for the three months ended March 31, 2025, before giving effect to the impact of the interest rate swaps, was 6.3% and after giving effect to the impact of the interest rate swaps, was 5.5%.

14


 

The Company’s obligations under the 2025 Credit Facility are guaranteed by certain of the Company’s existing and future direct and indirect subsidiaries, and such obligations are secured by substantially all of the Company’s assets, including the capital stock or other equity interests in those subsidiaries.

As of March 31, 2026, the Company had the following interest rate swap agreements in place:

Effective date

 

Expiration date

 

Notional amount

 

 

Fixed rate

 

Floating rate

5/30/2023

 

4/27/2026

 

$

70,000,000

 

 

3.880%

 

USD-SOFR

6/5/2024

 

6/27/2027

 

$

80,000,000

 

 

3.270%

 

USD-SOFR

4/1/2025

 

4/27/2028

 

$

50,000,000

 

 

3.625%

 

USD-SOFR

Loan and Aircraft Security Agreement—On May 18, 2023, the Company entered into a Loan and Aircraft Security Agreement to finance $10.9 million of the purchase a new aircraft (Aircraft Loan). The Aircraft Loan must be repaid in 60 monthly consecutive installments and all outstanding amounts will become due on May 18, 2028. The Aircraft Loan bears interest subject to 1-month Term SOFR and a spread of 1.86%. The entire principal balance may be prepaid in full subject to a 3.0%, 2.0% and 1.0% prepayment fee if paid prior to the first, second and third anniversary of the loan, respectively. The aircraft serves as collateral security for the Aircraft Loan.

The following is a schedule of the aggregate annual maturities of long-term debt (excluding current portion) presented on the unaudited condensed consolidated statement of financial position as of March 31, 2026, before deferred debt issuance cost of $1.9 million, based on the terms of the 2025 Credit Facility and the Aircraft Loan:

 

 

2025 Credit Facility

 

 

 

 

 

 

 

Term Loan

 

Revolving Line of Credit

 

Aircraft Loan

 

Total

 

2027

 

 

7,500

 

 

 

 

997

 

 

8,497

 

2028

 

 

10,000

 

 

 

 

577

 

 

10,577

 

2029

 

 

10,000

 

 

 

 

5,000

 

 

15,000

 

2030

 

 

157,500

 

 

120,441

 

 

 

 

277,941

 

Total

 

$

185,000

 

$

120,441

 

$

6,574

 

$

312,015

 

 

13. FAIR VALUE OF FINANCIAL INSTRUMENTS

The following financial instruments are measured at fair value on a recurring basis using significant unobservable inputs (Level 3):

 

March 31, 2026

 

 

December 31, 2025

 

Interest rate swap(1)

$

281

 

 

$

 

Foreign currency forward contract(2)

 

421

 

 

 

 

Total Assets

$

702

 

 

$

 

 

 

 

 

 

 

Business acquisitions contingent consideration, current

$

6,942

 

 

$

14,883

 

Business acquisitions contingent consideration, long-term

 

1,858

 

 

 

2,755

 

Interest rate swap(1)

 

 

 

 

429

 

Total Liabilities

$

8,800

 

 

$

18,067

 

_____________________________

(1) Included in prepaid and other current assets and other non-current liabilities in the unaudited condensed consolidated statement of financial position as of March 31, 2026 and audited condensed consolidated statement of financial position as of December 31, 2025, respectively.

(2) Included in prepaid and other current assets in the unaudited condensed consolidated statement of financial position as of March 31, 2026.

The estimated fair value amounts shown above are not necessarily indicative of the amounts that the Company would realize upon disposition, nor do they indicate the Company’s intent or ability to dispose of the financial instrument.

15


 

The following table sets forth the Company’s financial instruments that were measured at fair value on a recurring basis:

 

Interest Rate Swap

 

 

Foreign Currency Forward Contract

 

 

Total Assets

 

 

Business Acquisitions Contingent Consideration, Current

 

 

Business Acquisitions Contingent Consideration, Long-term

 

 

Conversion Option Related to Series A-2 Preferred Stock

 

 

Interest Rate Swap

 

 

Total Liabilities

 

Balance as of December 31, 2024

$

1,544

 

 

$

 

 

$

1,544

 

 

$

26,872

 

 

$

6,255

 

 

$

20,224

 

 

$

 

 

$

53,351

 

Changes in fair value included in earnings

 

(908

)

 

 

 

 

 

(908

)

 

 

(713

)

 

 

1,141

 

 

 

308

 

 

 

 

 

 

736

 

Payment of contingent consideration payable

 

 

 

 

 

 

 

 

 

 

(6,855

)

 

 

 

 

 

 

 

 

 

 

 

(6,855

)

Reclass of short term to long term contingent liabilities

 

 

 

 

 

 

 

 

 

 

(4,252

)

 

 

4,252

 

 

 

 

 

 

 

 

 

 

Balance as of March 31, 2025

$

636

 

 

$

 

 

$

636

 

 

$

15,052

 

 

$

11,648

 

 

$

20,532

 

 

$

 

 

$

47,232

 

Balance as of December 31, 2025

$

 

 

$

 

 

$

 

 

$

14,883

 

 

$

2,755

 

 

$

 

 

$

429

 

 

$

18,067

 

Changes in fair value included in earnings

 

281

 

 

 

421

 

 

 

702

 

 

 

59

 

 

 

(897

)

 

 

 

 

 

(429

)

 

 

(1,267

)

Payment of contingent consideration payable

 

 

 

 

 

 

 

 

 

 

(8,000

)

 

 

 

 

 

 

 

 

 

 

 

(8,000

)

Balance as of March 31, 2026

$

281

 

 

$

421

 

 

$

702

 

 

$

6,942

 

 

$

1,858

 

 

$

 

 

$

 

 

$

8,800

 

 

14. COMMITMENTS AND CONTINGENCIES

Leases—The Company leases office facilities over various terms expiring through 2040. Certain of these operating leases contain rent escalation clauses. The Company also has office equipment leases that expire through 2045 (Note 6 and 12).

Other CommitmentsThe Company has commitments under the 2025 Credit Facility, its Aircraft Loan, its equipment line of credit and its lease obligations (Note 6 and 12). The Company has entered into a purchase contract to purchase a total of $4.9 million of equipment over the course of 7 years that commenced on July 1, 2024, subject to a minimum spending requirement per year, measured from the commencement date and each anniversary thereof. The minimum spend requirement is $0.4 million and $0.9 million for 2026 and 2027, respectively, with the remainder subject to mutual agreement after 2027. No purchases were made during the three months ended March 31, 2026 and 2025.

Contingencies—The Company is subject to purchase price contingencies related to earn-outs associated with certain acquisitions (Note 7 and 13).

Legal—In the normal course of business, the Company is at times subject to pending and threatened legal actions. In management’s opinion, any potential loss resulting from the resolution of these matters is not expected to have a material effect on the unaudited condensed consolidated results of operations, financial position or cash flows of the Company.

15. CONVERTIBLE AND REDEEMABLE SERIES A-2 PREFERRED STOCK

On April 13, 2020, the Company entered into an agreement to issue 17,500 shares of the Convertible and Redeemable Series A-2 Preferred Stock with a par value of $0.0001 per share and a detachable warrant to purchase shares of the Company’s common stock with a 10-year life, in exchange for gross proceeds of $175.0 million, net of $1.3 million debt issuance costs. The Convertible and Redeemable Series A-2 Preferred Stock warrants were exercised in full on July 30, 2020. On April 1, 2025, the Company redeemed $60.0 million in aggregate stated value of the outstanding Series A-2 Preferred Stock. On July 1, 2025, the Company redeemed the remaining $62.2 million in aggregate stated value of the outstanding Series A-2 Preferred Stock. The Company funded each 2025 redemption with cash on hand and borrowings under the 2025 Credit Facility. Following the July 2025 redemption, no A-2 Preferred Shares remained outstanding. Both 2025 redemptions were reflected, net of applicable excise tax, in the Company's unaudited condensed consolidated statements of convertible and redeemable series A-2 preferred stock and stockholders’ equity and resulted in a reduction of temporary equity.

The Convertible and Redeemable Series A-2 Preferred Stock had a dividend rate of 9.0% per year with required quarterly cash payments. Dividends on the Convertible and Redeemable Series A-2 Preferred Stock accrued through the date of the Company’s initial public offering on July 23, 2020, and were added to the principal balance outstanding as of that date. All dividends on the Convertible and Redeemable Series A-2 Preferred Stock after that date were paid in cash. The Company paid dividends on shares of the Convertible and Redeemable Series A-2 Preferred Stock of $2.8 million during the three months ended March 31, 2025.

16


 

The Convertible and Redeemable Series A-2 Preferred Stock contained a conversion option of the preferred shares to shares of common stock beginning in April 2024. The change in net fair value of $0.3 million for the three months ended March 31, 2025 was recorded to other (income) expense.

16. STOCKHOLDERS’ EQUITY

Stock Repurchase Program

On May 6, 2025, the Board of Directors approved a stock repurchase program of up to $40.0 million. The repurchase program does not have a set expiration date. During the three months ended March 31, 2026, the Company repurchased 376,313 shares of its common stock for approximately $10.0 million, inclusive of transaction fees. Repurchased shares are accounted for as treasury stock and are presented as a deduction from total equity in the Company's unaudited condensed consolidated statements of convertible and redeemable series A-2 preferred stock and stockholders’ equity. As of March 31, 2026, approximately $30.0 million of the authorized capacity under the repurchase program remained available for future repurchases.

Employee Equity Incentive Plans

The Company has two plans under which stock-based awards have been issued: (i) the Amended & Restated 2017 Stock Incentive Plan (2017 Plan) and (ii) the Amended & Restated 2013 Stock Option Plan (2013 Plan) (collectively the Plans).

The following number of shares were authorized to be issued and available for grant:

 

March 31, 2026

 

 

2017 Plan

 

 

2013 Plan

 

 

Total

 

Shares authorized to be issued

 

10,350,585

 

 

 

2,032,719

 

 

 

12,383,304

 

Shares available for grant(1)

 

3,191,988

 

 

 

 

 

 

3,191,988

 

 

 

 

 

 

 

 

 

 

 

March 31, 2025

 

 

2017 Plan

 

 

2013 Plan

 

 

Total

 

Shares authorized to be issued

 

8,911,649

 

 

 

2,035,219

 

 

 

10,946,868

 

Shares available for grant(1)

 

1,837,660

 

 

 

 

 

 

1,837,660

 

 

(1) In January 2026 and January 2025 the Board of Directors ratified the addition of 1,436,436 and 1,372,373 shares of common stock, respectively, to the number of shares available for issuance under the 2017 Plan pursuant to the annual increase provision of such plan. Unless the Board of Directors determines otherwise, additional annual increases will be effective on each January 1, through January 1, 2027. The 2017 Plan permits the company to settle awards, if and when vested, in cash at its discretion. Pursuant to the terms of the 2017 Plan, the number of shares authorized for issuance thereunder will only be reduced with respect to shares of common stock actually issued upon exercise or settlement of an award. Shares of common stock subject to awards that have been canceled, expired, forfeited or otherwise not issued under an award and shares of common stock subject to awards settled in cash do not count as shares of common stock issued under the 2017 Plan.

17. NET LOSS PER SHARE

Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted average number of common shares outstanding during each period. The Convertible and Redeemable Series A-2 Preferred Stock was considered a participating security during the prior year period. Net losses were not allocated to the Convertible and Redeemable Series A-2 stockholders, as they were not contractually obligated to share in the Company’s losses.

Diluted net loss per share is computed by dividing net loss attributable to common stockholders by the weighted average number of common and dilutive common equivalent shares outstanding for the period using the treasury-stock method or the if-converted method. Potentially dilutive shares are comprised of awards of restricted stock (RSAs), restricted stock units (RSUs), and shares of common stock underlying stock options outstanding under the Company's stock incentive plans, as applicable. During the three months ended March 31, 2026 and 2025 there was no difference in the number of shares used to calculate basic and diluted shares outstanding during the applicable period due to the Company’s net loss attributable to common stockholders and potentially dilutive shares being anti-dilutive.

17


 

The following table summarizes the computation of basic and diluted net loss per share attributable to common stockholders of the Company:

 

 

Three Months Ended March 31,

 

 

 

2026

 

 

2025

 

Net loss

 

$

(12,690

)

 

$

(19,359

)

Convertible and Redeemable Series A-2 Preferred Stock dividend

 

 

 

 

 

(2,750

)

Net loss attributable to common stockholders - basic and diluted

 

 

(12,690

)

 

 

(22,109

)

Weighted-average shares of common stock outstanding – basic and diluted

 

 

36,045

 

 

 

34,502

 

Net loss per share attributable to common stockholders – basic and diluted

 

$

(0.35

)

 

$

(0.64

)

The following common stock equivalents were excluded from the calculation of diluted net loss per share attributable to common stockholders for the three months ended March 31, 2026 and the three months ended March 31, 2025 because their effect would have been anti-dilutive:

 

 

March 31,

 

 

 

2026(1)

 

 

2025(1)

 

Stock options

 

 

2,556,885

 

 

 

3,758,697

 

Restricted stock

 

 

2,698,433

 

 

 

3,400,070

 

Series A-2 Preferred Stock

 

 

 

 

 

6,836,990

 

_____________________________

(1) Includes 1,990,423 and 2,411,688 common stock equivalents that are out of the money as of March 31, 2026 and March 31, 2025, respectively.

18. STOCK-BASED PLANS AND COMPENSATION

There were no stock-based compensation expenses related to the 2013 Plan in the three months ended March 31, 2026 and 2025. Total stock-based compensation expense related to the 2017 Plan was as follows:

 

Three Months Ended March 31,

 

 

2026

 

 

2025

 

 

Options

 

 

RSUs

 

 

Total

 

 

Options

 

 

RSUs

 

 

Total

 

Cost of revenue

$

128

 

 

$

778

 

 

$

906

 

 

$

189

 

 

$

2,081

 

 

$

2,270

 

Selling, general and administrative expense

 

151

 

 

 

8,016

 

 

 

8,167

 

 

 

250

 

 

 

11,203

 

 

 

11,453

 

Total

$

279

 

 

$

8,794

 

 

$

9,073

 

 

$

439

 

 

$

13,284

 

 

$

13,723

 

As of March 31, 2026 and March 31, 2025, there was $54.0 million and $76.7 million, respectively, of total unrecognized stock-based compensation expense related to unvested options and restricted stock under the 2017 Plan. Such unrecognized expense is expected to be recognized over a weighted-average 2.1 year period.

Amended & Restated 2017 Stock Incentive Plan

Restricted Stock Awards and Restricted Stock Units

RSAs and RSUs activity was as follows:

 

Three Months Ended March 31,

 

 

2026

 

 

2025

 

 

Shares

 

 

Weighted-Average Grant Date Fair Value

 

 

Shares

 

 

Weighted-Average Grant Date Fair Value

 

Beginning outstanding shares

 

2,324,404

 

 

 

 

 

 

2,617,059

 

 

 

 

Granted

 

687,076

 

 

$

26.56

 

 

 

1,268,832

 

 

$

17.63

 

Forfeited/ cancelled

 

(55,981

)

 

$

27.40

 

 

 

(19,242

)

 

$

38.25

 

Vested

 

(257,066

)

 

$

29.22

 

 

 

(466,579

)

 

$

24.06

 

Ending outstanding shares

 

2,698,433

 

 

 

 

 

 

3,400,070

 

 

 

 

Options

18


 

The following summarizes the options activity of the 2017 Plan:

 

Options to Purchase Common Stock

 

 

Weighted-Average Exercise Price per Share

 

 

Weighted Average Grant Date Fair Value per Share

 

 

Weighted Average Remaining Contract Life (in Years)

 

 

Aggregate Intrinsic Value of In-The-Money Options

 

Outstanding as of December 31, 2024

 

2,345,207

 

 

$

30.62

 

 

$

16.32

 

 

 

6.0

 

 

$

776

 

Forfeited/ cancelled

 

(19,710

)

 

 

42.74

 

 

 

 

 

 

 

 

 

 

Expired

 

(10,815

)

 

 

34.53

 

 

 

 

 

 

 

 

 

 

Outstanding as of March 31, 2025

 

2,314,682

 

 

$

30.50

 

 

$

16.32

 

 

 

5.7

 

 

$

9

 

Outstanding as of December 31, 2025

 

2,193,528

 

 

$

30.33

 

 

 

16.32

 

 

 

4.9

 

 

 

6,109

 

Forfeited/ cancelled

 

(3,520

)

 

 

38.53

 

 

 

 

 

 

 

 

 

 

Expired

 

(23,315

)

 

 

40.86

 

 

 

 

 

 

 

 

 

 

Exercised

 

(32,511

)

 

 

18.23

 

 

 

 

 

 

 

 

 

300

 

Outstanding as of March 31, 2026

 

2,134,182

 

 

$

30.38

 

 

$

16.32

 

 

 

4.7

 

 

$

4,054

 

Exercisable as of March 31, 2026

 

2,016,334

 

 

$

30.04

 

 

 

 

 

 

4.6

 

 

$

4,054

 

Amended & Restated 2013 Stock Option Plan

The following summarizes the activity of the 2013 Plan:

 

Options to Purchase Common Stock

 

 

Weighted-Average Exercise Price per Share

 

 

Weighted Average Grant Date Fair Value per Share

 

 

Weighted Average Remaining Contract Life (in Years)

 

 

Aggregate Intrinsic Value of In-The-Money Options

 

Outstanding as of December 31, 2024

 

680,889

 

 

$

6.49

 

 

$

2.51

 

 

 

1.5

 

 

$

8,211

 

Expired

 

(1,000

)

 

 

6.03

 

 

 

 

 

 

 

 

 

 

Exercised

 

(7,395

)

 

 

8.23

 

 

 

 

 

 

 

 

 

5,237

 

Outstanding as of March 31, 2025

 

672,494

 

 

$

6.47

 

 

$

2.51

 

 

 

1.3

 

 

$

5,237

 

Outstanding as of December 31, 2025

 

567,827

 

 

$

6.51

 

 

 

2.51

 

 

 

0.5

 

 

 

10,401

 

Exercised

 

(296,907

)

 

 

6.17

 

 

 

 

 

 

 

 

 

6,213

 

Outstanding as of March 31, 2026

 

270,920

 

 

$

6.89

 

 

$

2.51

 

 

 

0.3

 

 

$

4,064

 

Exercisable as of March 31, 2026

 

270,920

 

 

$

6.89

 

 

 

 

 

 

0.3

 

 

$

4,064

 

Common Stock Reserved for Future IssuancesThe Company has reserved certain stock of its authorized but unissued common stock for possible future issuance in connection with the following:

 

March 31,

 

 

2026

 

 

2025

 

2013 Stock Incentive Plan

 

270,920

 

 

 

672,494

 

2017 Stock Incentive Plan(1)

 

8,024,892

 

 

 

7,552,412

 

 

 

8,295,812

 

 

 

8,224,906

 

 

(1) In January 2026 and 2025, the Board of Directors ratified the addition of 1,436,436 and 1,372,373 shares of common stock, respectively, to the number of shares available for issuance under the 2017 Plan pursuant to the annual increase provision of such plan. Unless the Board of Directors determines otherwise, additional annual increases will be effective on each January 1, through January 1, 2027. The 2017 Plan permits the company to settle awards, if and when vested, in cash at its discretion. Pursuant to the terms of the 2017 Plan, the number of shares authorized for issuance thereunder will only be reduced with respect to shares of common stock actually issued upon exercise or settlement of an award. Shares of common stock subject to awards that have been canceled, expired, forfeited or otherwise not issued under an award and shares of common stock subject to awards settled in cash do not count as shares of common stock issued under the 2017 Plan. The Company expects to have sufficient shares available under the 2017 Plan to satisfy the future settlement of outstanding awards.

19


 

19. SEGMENT INFORMATION

Historically, the Company had six operating units that aggregate into three reportable segments: Assessment, Permitting and Response, Measurement and Analysis, and Remediation and Reuse. Effective in the first quarter of 2026, the Company realigned its reportable segments to reflect changes in its organizational structure and operating model. As a result of these changes, the Company now manages two reportable segments, namely Consulting and Treatment and Measurement and Analysis. Specifically, the Assessment, Permitting and Response segment and Remediation and Reuse segment were aggregated into the new Consulting and Treatment segment based on their similar characteristics, including similar long-term financial performance, the nature of services provided, internal processes for delivering those services, and types of customers. The Company's Measurement and Analysis and corporate segments were not affected by the realignment.

These segments are monitored separately by management for performance against budget and prior year and are consistent with internal financial reporting. The Company’s operating segments are organized based upon primary services provided, the nature of the production process, types of customers, methods used to distribute the products, and the nature of the regulatory environment. Refer to Note 1 for description of each reportable segment.

The Company's Chief Executive Officer, who serves as the Chief Operating Decision Maker (CODM), reviews Segment Adjusted EBITDA in the annual budget and forecasting process. The CODM considers budget-to-actual variances on a quarterly basis when making decisions about the allocation of Company resources depending on the needs of each segment and the availability of resources. Segment Adjusted EBITDA is the calculated Company’s Earnings before Interest, Tax, Depreciation and Amortization (EBITDA), adjusted to exclude certain transactions such as stock-based compensation, acquisition costs, and fair value changes in financial instruments, amongst others. The CODM does not review segment assets as a measure of segment performance. Effective in the first quarter of 2026, the Company updated its reportable segments to reflect changes in its organizational structure and internal reporting described above. Accordingly, the Company’s updated segments represent the components whose operating results are regularly reviewed by the CODM to make decisions about the allocation of resources and to assess performance.

Corporate and Other includes costs associated with general corporate overhead (including executive, legal, finance, safety, human resources, marketing and IT related costs) that are not directly related to supporting operations. Overhead costs that are directly related to supporting operations (such as insurance, software, licenses, shared services and payroll processing costs) are allocated to the operating segments on a basis that reasonably approximates an estimate of the use of these services, and are included in Segment Expenses in the table below.

The following table presents Segment Revenues, Segment Expenses and Segment Adjusted EBITDA, with prior period information recast to reflect the above change in segment reporting:

 

 

Three Months Ended March 31,

 

 

 

2026

 

 

2025

 

(in thousands)

 

Segment Revenues

 

 

Segment Expenses

 

 

Segment Adjusted EBITDA

 

 

Segment Revenues

 

 

Segment Expenses

 

 

Segment Adjusted EBITDA

 

Consulting and Treatment

 

$

114,587

 

 

$

94,454

 

 

$

20,133

 

 

$

118,804

 

 

$

102,305

 

 

$

16,499

 

Measurement and Analysis

 

 

53,931

 

 

 

43,994

 

 

 

9,937

 

 

 

59,030

 

 

 

45,257

 

 

 

13,773

 

Total Reportable Segments

 

$

168,518

 

 

 

 

 

$

30,070

 

 

$

177,834

 

 

 

 

 

$

30,272

 

Presented below is a reconciliation of the Company’s segment measure to loss before expense from income taxes:

 

 

For the Three Months Ended March 31,

 

 

 

2026

 

 

2025

 

Total Reportable Segments

 

$

30,070

 

 

$

30,272

 

Corporate and Other

 

 

(12,247

)

 

 

(11,242

)

Interest expense, net

 

 

(5,466

)

 

 

(5,065

)

Depreciation and amortization

 

 

(12,629

)

 

 

(13,294

)

Stock-based compensation

 

 

(9,073

)

 

 

(13,723

)

Acquisition costs(1)

 

 

(81

)

 

 

(711

)

Fair value changes in financial instruments(2)

 

 

710

 

 

 

(1,216

)

Fair value changes in business acquisition contingencies

 

 

838

 

 

 

(477

)

Non-recurring rebranding expenses

 

 

(1,101

)

 

 

 

Other losses or expenses(3)

 

 

(1,408

)

 

 

(1,032

)

Loss before expense from income taxes

 

$

(10,387

)

 

$

(16,488

)

__________________________

20


 

(1) Includes financial and tax diligence, consulting, legal, valuation, accounting, travel and acquisition-related incentives related to the Company's acquisition and integration activity.

(2) The three months ended March 31, 2026 consist primarily of the change in fair value of the interest rate swap instruments. The three months ended March 31, 2025 consist primarily of the change in fair value of the interest rate swap instruments and the embedded derivative attached to the Series A-2 preferred stock.

(3) The three months ended March 31, 2026 consist primarily of IT migration costs. The three months ended March 31, 2025 consist primarily of non-recurring costs incurred to restructure the Company's renewable energy business, third party expenses associated with the independent review and analysis of assertions in a short seller report regarding the Company and costs to centralize certain back-office functions.

The following table presents revenues by geographic location:

 

 

For the Three Months Ended March 31,

 

 

 

2026

 

 

2025

 

United States

 

$

135,034

 

 

$

145,936

 

Canada

 

 

25,784

 

 

 

24,649

 

Other international

 

 

7,700

 

 

 

7,249

 

Total revenue

 

$

168,518

 

 

$

177,834

 

The following table presents long-lived assets by geographic location:

 

 

March 31,

 

 

December 31,

 

 

 

2026

 

 

2025

 

United States

 

$

60,943

 

 

$

58,590

 

Canada

 

 

4,094

 

 

 

4,311

 

Other international

 

 

1,022

 

 

 

952

 

Total property and equipment—net

 

$

66,059

 

 

$

63,853

 

 

20. RELATED-PARTY TRANSACTIONS

The Company did not have any material related party transactions during the three months ended March 31, 2026 and 2025.

21. DEFINED CONTRIBUTION PLAN

On January 1, 2014, the Company established the Company's 401(k) Savings Plan (the 401(k) Savings Plan). As of March 31, 2026, and December 31, 2025, plan participants may defer up to 85.0% of their eligible wages for the year, up to the Internal Revenue Service dollar limit and catch-up contribution allowed by law. The Company provided employer matching contributions equal to 100.0% of the first 3.0% of the participant’s compensation and 50.0% of the participant’s elective deferrals that exceed 3.0% but do not exceed 5.0% of the participant’s compensation. Employer contributions under the 401(k) Savings Plan were $3.6 million for the three months ended March 31, 2026 and $2.8 million for the three months ended March 31, 2025.

21


 

FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. These forward-looking statements relate to matters such as our industry, business strategy, goals and expectations concerning our market position, future operations, margins, profitability, capital expenditures, liquidity, capital resources and other financial and operating information. We use words such as “anticipate,” “assume,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “future,” “intend,” “may,” “plan,” “position,” “potential,” “predict,” “project,” “seek,” “should,” “target,” “will” and similar terms and phrases to identify forward-looking statements in this filing. All of our forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those that we are expecting, including:

general global economic, business and other conditions, including inflationary and interest rate pressures and tariffs and other trade tensions, the cyclical nature of our industry and the significant fluctuations in events that impact our business;
the parts of our business that depend on difficult to predict natural or manmade events and the fluctuations in our revenue and customer concentration as a result thereof;
our ability to adapt to changing technology, industry standards or regulatory requirements, including emerging environmental, social and governance requirements;
the highly competitive nature of our business;
significant environmental governmental regulation or de-regulation;
our ability to execute on our acquisition strategy and successfully integrate and realize benefits from our acquisitions;
our ability to maintain and expand our client base;
our ability to attract and retain qualified managerial and skilled technical personnel;
safety-related issues;
any failure in or breach of our networks and systems or other forms of cyber-attack;
our ability to promote and develop our new brand;
our ability to maintain necessary accreditations and other authorizations in varying jurisdictions;
allegations regarding compliance with professional standards, duties and statutory obligations and our ability to provide accurate results;
the lack of formal long-term agreements with many of our clients;
government clients and contracts;
our ability to maintain our prices and manage costs;
our ability to protect our intellectual property or claims that we infringe on the intellectual property rights of others;
laws and regulations regarding handling of confidential information;
our international operations;
product related risks; and
additional factors discussed in our filings with the Securities and Exchange Commission, or the SEC.

The forward-looking statements in this Quarterly Report on Form 10-Q are based on historical performance and management’s current plans, estimates and expectations in light of information currently available to us and are subject to uncertainty and changes in circumstances. There can be no assurance that future developments affecting us will be those that we have anticipated. Actual results or outcomes may differ materially from these expectations due to changes in global, regional or local political, economic, business, competitive, market, regulatory and other factors, many of which are beyond our control, as well as the other factors described in Item 1A. “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025 filed with the SEC on February 26, 2026, or the 2025 Form 10-K.

Additional factors or events that could cause our actual results or outcomes to differ may also emerge from time to time, and it is not possible for us to predict all of them. In addition, historical, current and forward-looking sustainability-related statements may be based on standards for measuring progress that are still developing, internal controls and processes that continue to evolve, and assumptions that are subject to change in the future. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove to be incorrect, our actual results or outcomes may vary in material respects from what we may have expressed or implied by any forward-looking statement and, therefore, you

22


 

should not regard any forward-looking statement as a representation or warranty by us or any other person that we will successfully achieve the expectation, plan or objective expressed in such forward-looking statement in any specified time frame, or at all. We caution that you should not place undue reliance on any of our forward-looking statements. Any forward-looking statement made by us speaks only as of the date on which we make it. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by applicable securities laws.

 

23


 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our historical audited and unaudited consolidated financial statements and related notes and other information included elsewhere in this filing and our other filings with the SEC, including our unaudited condensed consolidated financial statements and the accompanying notes as of and for the three months ended March 31, 2026 and 2025 included in Part I, Item 1. “Financial Statements” in this Quarterly Report on Form 10-Q. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from such forward-looking statements. Factors that could cause or contribute to those differences include, but are not limited to, those identified below and those discussed in the section entitled “Forward-Looking Statements”, and elsewhere in this filing and our other filings with the SEC, including in Item 1A. Risk Factors in the 2025 Form 10-K.

Overview

Since our inception in 2012, our mission has been to help clients and communities meet their environmental goals and needs. According to data derived from a 2025 Environmental Industry Study prepared by Environmental Business International, Inc., or EBI, the global environmental industry is estimated to generate approximately $1.9 trillion in revenues in 2026, with $620.0 billion concentrated in the United States.

Our Segments

Historically, the Company had three business segments—Assessment, Permitting and Response, Measurement and Analysis and Remediation and Reuse. Effective in the first quarter of 2026, we realigned two of our reportable segments to reflect updates made to our organizational structure and operating model. As a result of these changes, we aggregated the Assessment, Permitting and Response and Remediation and Reuse segments into a newly created Consulting and Treatment segment. The Company's Measurement and Analysis and corporate segments were not affected by the realignment.

We have conformed our presentation for all prior periods presented to reflect its revised segment reporting. See Notes 1 and 19 to our unaudited condensed consolidated financial statements included in Part 1, Item 1 “Financial Statements.”

Consulting and Treatment

The Consulting and Treatment segment provides environmental consulting, engineering, and implementation services to support clients in managing environmental objectives and regulatory requirements.

Measurement and Analysis

The Measurement and Analysis segment provides environmental testing and laboratory services, including the analysis of air, water, and soil.

These segments collectively support clients across the lifecycle of their operations, from assessment and compliance to monitoring and remediation. These operating segments have been structured to align with how we view and manage the business with the full lifecycle of our clients’ targeted environmental objectives in mind. Within each segment, we cover service offerings within similar regulatory frameworks, internal operating structures and client types. Corporate activities not directly related to segment performance, including general corporate expenses, interest and taxes, are reported separately.

Key Factors that Affect Our Business and Our Results

Our operating results and financial performance are influenced by a variety of internal and external trends and other factors. Some of the more important factors are discussed briefly below.

Acquisitions

Although we did not consummate any acquisitions in the three months ended March 31, 2026, or the year ended 2025, we have been, and expect to continue to be, an acquisitive company. Acquisitions expanded our environmental service capabilities across our segments, our access to technology, as well as our geographic reach in the United States, Canada, and Australia.

24


 

As a result of our acquisitions, goodwill and other intangible assets represent a significant proportion of our total assets, and amortization of intangible assets has historically been a significant expense. Our historical financial statements also include other acquisition-related costs, including costs relating to external legal support, diligence and valuation services and other transaction and integration-related matters. In addition, in any year gains and losses from changes in the fair value of business acquisition contingencies such as earn-outs could be significant. The amount of each for the three months ended March 31, 2026 and 2025, was:

 

 

Three Months Ended March 31,

 

 

(in thousands)

 

2026

 

 

2025

 

 

Amortization expense

 

$

6,674

 

 

$

8,390

 

 

Acquisition-related costs

 

 

81

 

 

 

711

 

 

Fair value changes in business acquisition contingencies

 

 

(838

)

 

 

477

 

 

We expect that amortization of identifiable intangible assets and other acquisition-related costs, assuming we continue to acquire, will continue to be significant.

During the three months ended March 31, 2026, we made a contingent consideration cash payment of $8.0 million for Origins Laboratory, Inc. During the three months ended March 31, 2025, we made contingent consideration payments of $6.6 million in the Company's common stock, of which $4.8 million related to deferred consideration payments for the acquisition of Epic Environmental Pty Ltd (Epic), and $1.8 million related to earn-out payments for SensibleIoT, LLC.

In connection with certain of our acquisitions, we may make up to $9.6 million in aggregate earn-out payments between the years 2026 and 2027, of which up to $5.1 million may be paid only in cash, up to $2.8 million may be paid only in common stock and up to $1.7 million may be paid, at our option, in cash or common stock. See Note 7 to our unaudited condensed consolidated financial statements included in Part I, Item 1. “Financial Statements.”

Organic Growth

We define organic growth as the change in revenues excluding revenues from (i) our environmental emergency response business, (ii) acquisitions for the first twelve months following the date of acquisition, and (iii) businesses held for sale, disposed of or discontinued. Management uses organic growth as one of the means by which it assesses our results of operations. Organic growth is not, however, a measure of revenue growth calculated in accordance with U.S. generally accepted accounting principles, or GAAP, and should be considered in conjunction with revenue growth calculated in accordance with GAAP. We have grown organically over the long term and expect to continue to do so.

Revenue Mix

Our segments and our business lines within each segment generate different levels of profitability and, accordingly, shifts in the mix of revenues between segments can impact our consolidated reported net income or loss, net income or loss margin, Segment Adjusted EBITDA and Segment Adjusted EBITDA margin from quarter to quarter and year to year. Inter-company revenues between business lines within segments have been eliminated. See Note 19 to our unaudited condensed consolidated financial statements included in Part 1, Item 1 “Financial Statements.”

Our revenues and certain expenses, including selling, general and administrative expense, vary from period to period due primarily to changes in organic growth, the incremental contribution from recent acquisitions and strategic decisions we may make from time to time. When we refer to changes driven by organic growth, we are referring to the contribution from businesses that have been part of Onterris for more than 12 months, with certain limited exclusions as discussed in greater detail above. In a given reporting period, when we refer to revenue changes driven by acquisitions, we are referring to the revenue contribution from any acquisition from its closing date through the first 12 months of that acquisition, at which point any subsequent revenue contribution therefrom would be organic.

Financing Costs

Financing costs are driven by interest incurred on our outstanding borrowings under the 2025 Credit Facility, as well as fees paid on the unutilized capacity of the facility and outstanding letters of credit issued under the facility. Interest is also incurred on outstanding borrowings under the Aircraft Loan and amounts outstanding under our capital lease facilities. Financing costs also include the amortization or write-offs of deferred debt issuance costs and amounts paid under our interest rate swaps. Amounts received related to our interest rate swaps are netted against financing costs.

Total debt, net of deferred debt issuance costs, at March 31, 2026 was $321.4 million, which was an increase of $33.1 million compared to December 31, 2025. The increase was primarily driven by an increase of $35.8 million outstanding under our revolving line of credit.

25


 

Interest expense, net was $5.5 million in the three months ended March 31, 2026 and $5.1 million in the three months ended March 31, 2025. We expect interest expense to remain a significant cost as we continue to leverage our 2025 Credit Facility to support our operations and future acquisitions. Our 2025 Credit Facility funded a portion of the redemption of the Series A-2 Preferred Stock in April and July 2025.

In February 2025, we refinanced our 2021 Credit Facility and replaced it with a new 2025 Credit Facility. See Note 12 to our unaudited condensed consolidated financial statements included in Part 1, Item 1 “Financial Statements” and “Liquidity and Capital Resources.”

Corporate and Operational Infrastructure Investments

Our historical operating results reflect the impact of our ongoing investments in our corporate infrastructure to support our growth. We have made and expect to continue to make investments in our business platform that we believe have laid the foundation for continued growth. Investments in logistics, quality, risk management, sales and marketing, safety, human resources, research and development, finance and information technology and other areas enable us to support continued growth. These investments should allow us to improve our margins over time.

Seasonality

Due to the field-based nature of certain of our services, weather patterns generally impact our field-based teams’ ability to operate in the winter months. As a result, our operating results experience quarterly variability with generally lower revenues and lower earnings in the first and fourth quarters and higher overall revenues and earnings in the second and third quarters. As we continue to grow and expand into new geographies and service lines, quarterly variability may deviate from historical trends.

Earnings Volatility

In addition to the impact of seasonality on earnings, our environmental emergency response business exposes us to potentially significant revenue and earnings fluctuations tied to large environmental emergency response projects following an incident or natural disaster or more broad scale events. Total revenue from emergency response related services was $8.1 million and $13.9 million for the three months ended March 31, 2026 and 2025, respectively. Demand for environmental emergency response services remains difficult to predict and as a result, we may have experienced revenues and earnings in prior years that are not indicative of future results, making those periods particularly difficult comparisons for future periods. Earnings volatility is also driven by the timing of large projects, particularly in our Consulting and Treatment segment, and the impact of acquisitions. As a result of these factors, and because demand for environmental services is not driven by specific or predictable patterns in one or more fiscal quarters, our business is better assessed based on annual results.

26


 

Results of Operations

The Three Months Ended March 31, 2026 Compared to the Three Months Ended March 31, 2025

 

 

Three Months Ended March 31,

 

(in thousands, except per share data)

 

2026

 

 

2025

 

Revenues

 

$

168,518

 

 

$

177,834

 

Cost of revenues (exclusive of depreciation and amortization)

 

 

101,468

 

 

 

108,406

 

Selling, general and administrative expense

 

 

61,322

 

 

 

66,232

 

Fair value changes in business acquisition contingencies

 

 

(838

)

 

 

477

 

Depreciation and amortization

 

 

12,629

 

 

 

13,294

 

Loss from operations

 

 

(6,063

)

 

 

(10,575

)

Other income (expense), net

 

 

1,142

 

 

 

(848

)

Interest expense, net

 

 

(5,466

)

 

 

(5,065

)

Loss before income taxes

 

 

(10,387

)

 

 

(16,488

)

Income tax expense

 

 

2,303

 

 

 

2,871

 

Net loss

 

$

(12,690

)

 

$

(19,359

)

Series A-2 dividend payment

 

 

 

 

 

(2,750

)

Net loss attributable to common stockholders

 

$

(12,690

)

 

$

(22,109

)

 

 

 

 

 

 

 

Weighted average common shares outstanding

 

 

 

 

 

 

Basic

 

 

36,045

 

 

 

34,502

 

Diluted

 

 

36,045

 

 

 

34,502

 

 

 

 

 

 

 

 

Net loss per share attributable to common stockholders

 

 

 

 

 

 

Basic

 

$

(0.35

)

 

$

(0.64

)

Diluted

 

$

(0.35

)

 

$

(0.64

)

Revenues

 

 

Three Months Ended March 31,

 

 

Change

 

(in thousands, except %)

 

2026

 

 

2025

 

 

$

 

 

%

 

Revenues

 

$

168,518

 

 

$

177,834

 

 

$

(9,316

)

 

 

(5.2

%)

Revenue for the three months ended March 31, 2026 decreased $9.3 million or 5.2% as compared to the three months ended March 31, 2025. The decrease was primarily driven by a decrease in environmental emergency response revenues of $5.8 million and a contraction of organic growth of $2.6 million as a result of lower revenues in the Measurement and Analysis segment, partially offset by organic growth in the Consulting and Treatment segment, and a $1.0 million decrease in revenues from exited European operations, which were exited in the fourth quarter of 2025. Environmental emergency response revenues were $8.1 million in the three months ended March 31, 2026, compared to $13.9 million in the three months ended March 31, 2025.

See “—Segment Results of Operations” below for revenue by segment analysis.

Cost of Revenues

 

 

Three Months Ended March 31,

 

 

Change

 

(in thousands, except %)

 

2026

 

 

2025

 

 

$

 

 

%

 

Cost of revenues (exclusive of depreciation and amortization)

 

$

101,468

 

 

$

108,406

 

 

$

(6,938

)

 

 

(6.4

%)

Cost of revenue as a % of revenue

 

 

60.2

%

 

 

61.0

%

 

 

 

 

 

 

 

27


 

Cost of revenues consists of all direct costs required to provide services, including fixed and variable direct labor costs, equipment purchases, and rental and other outside services, field and lab supplies, vehicle costs and travel-related expenses. Variable costs of revenues generally follow the same trends as revenue, while fixed costs tend to change primarily as a result of acquisitions.

Cost of revenues for the three months ended March 31, 2026 compared to the three months ended March 31, 2025 decreased by $6.9 million or 6.4% driven primarily by the decrease in revenues. Cost of revenues as a percentage of revenue for the three months ended March 31, 2026 was 60.2%, compared to 61.0% for the three months ended March 31, 2025. This improvement was driven primarily by costs incurred in the prior year period as part of the wind-down of our renewables business.

Selling, General and Administrative Expense

 

 

Three Months Ended March 31,

 

 

Change

 

(in thousands, except %)

 

2026

 

 

2025

 

 

$

 

 

%

 

Selling, general and administrative expense

 

$

61,322

 

 

$

66,232

 

 

$

(4,910

)

 

 

(7.4

%)

Selling, general and administrative expense consists of general corporate overhead, including executive, legal, finance, safety, risk management, human resource, marketing and information technology related costs, as well as indirect operational costs of labor, rent, insurance and stock-based compensation.

Selling, general and administrative expense for the three months ended March 31, 2026 compared to the three months ended March 31, 2025 decreased $4.9 million or 7.4% primarily due to a decrease of $3.3 million in stock-based compensation expense, $2.7 million in lower labor costs, which included a decrease in bonus accrual, and a $1.0 million year-over-year change in bad debt expense due to improved collections of aged accounts receivables, partially offset by higher IT expenses. Selling, general and administrative expense as a percentage of revenues decreased to 36.4% from 37.2% in the comparable period.

See Part I, Item 3. “Quantitative and Qualitative Disclosures About Market Risk” for additional information regarding the impact of inflation on our business.

Depreciation and Amortization

 

 

Three Months Ended March 31,

 

 

Change

 

(in thousands, except %)

 

2026

 

 

2025

 

 

$

 

 

%

 

Depreciation and amortization

 

$

12,629

 

 

$

13,294

 

 

$

(665

)

 

 

(5.0

%)

Depreciation and Amortization for the three months ended March 31, 2026 remained relatively consistent with the three months ended March 31, 2025 primarily due to the absence of significant changes in the underlying property and equipment and intangible asset base.

See Notes 5 and 6 to our unaudited condensed consolidated financial statements included in Part 1, Item 1. “Financial Statements.”

Other Income (Expense), Net

 

 

Three Months Ended March 31,

 

 

Change

 

(in thousands, except %)

 

2026

 

 

2025

 

 

$

 

 

%

 

Other income (expense), net

 

$

1,142

 

 

$

(848

)

 

$

1,990

 

 

 

(235

%)

Other income (expense), net for the three months ended March 31, 2026 was comprised of fair value gains of $0.7 million on our interest rate swaps and $0.4 million on our foreign currency forward contracts. Other income (expense), net for the three months ended March 31, 2025 was comprised of losses of $0.9 million related to a fair value adjustment on our interest rate swaps and a $0.3 million charge related to a fair value adjustment on the Series A-2 Preferred Stock conversion option, partially offset by $0.4 million of other income.

See Notes 13 and 15 to our unaudited condensed consolidated financial statements included in Part 1, Item 1. “Financial Statements.”

Interest Expense, Net

 

 

Three Months Ended March 31,

 

 

Change

 

(in thousands, except %)

 

2026

 

 

2025

 

 

$

 

 

%

 

Interest expense, net

 

$

(5,466

)

 

$

(5,065

)

 

$

(401

)

 

 

7.9

%

 

28


 

Interest expense, net for the three months ended March 31, 2026 increased compared to the three months ended March 31, 2025 primarily due to higher debt balances during the quarter, partially offset by lower interest rates.

Weighted average interest rates, after giving effect to the impact of the interest rate swaps, as of March 31, 2026 and March 31, 2025 were 5.6% and 5.5%, respectively. See “—Key Factors that Affect Our Business and Our Results—Financing Costs” and Notes 12 and 13 to our unaudited condensed consolidated financial statements included in Part I, Item 1. “Financial Statements.”

Income Tax Expense

 

 

Three Months Ended March 31,

 

 

Change

 

(in thousands, except %)

 

2026

 

 

2025

 

 

$

 

 

%

 

Income tax expense

 

$

2,303

 

 

$

2,871

 

 

$

(568

)

 

 

(19.8

%)

The income tax expense for the three months ended March 31, 2026 decreased compared to the three months ended March 31, 2025 primarily due to the One Big Beautiful Bill Act, which was signed into law in July 2025 and includes several significant favorable U.S. tax deductions for the Company.

Segment Results of Operations

The Three Months Ended March 31, 2026 Compared to the Three Months Ended March 31, 2025

The information below presents segment results in line with the new reporting segment structure effective in the first quarter of 2026. Prior year information has been recast to reflect the change in reporting segment structure.

 

 

Three Months Ended March 31,

 

 

 

2026

 

 

2025

 

(in thousands, except %)

 

Segment Revenues

 

 

Segment Adjusted EBITDA(1)

 

 

Segment Adjusted EBITDA Margin(2)

 

 

Segment Revenues

 

 

Segment Adjusted EBITDA(1)

 

 

Segment Adjusted EBITDA Margin(2)

 

Consulting and Treatment

 

$

114,587

 

 

$

20,133

 

 

 

17.6

%

 

$

118,804

 

 

$

16,499

 

 

 

13.9

%

Measurement and Analysis

 

 

53,931

 

 

 

9,937

 

 

 

18.4

 

 

 

59,030

 

 

 

13,773

 

 

 

23.3

 

Total Reportable Segments

 

$

168,518

 

 

$

30,070

 

 

 

17.8

%

 

$

177,834

 

 

$

30,272

 

 

 

17.0

%

Corporate and Other

 

 

 

 

$

(12,247

)

 

 

(7.3

)%

 

 

 

 

$

(11,242

)

 

 

(6.3

)%

 

(1)
For purposes of evaluating segment profit, the Company’s Chief Operating Decision Maker reviews Segment Adjusted EBITDA as a basis for making the decisions to allocate resources and assess performance. See Note 19 to our unaudited condensed consolidated financial statements included in Part I, Item 1. “Financial Statements.”
(2)
Represents Segment Adjusted EBITDA as a percentage of segment revenues.

Revenues

 

 

Three Months Ended March 31,

 

 

Change

 

(in thousands, except %)

 

2026

 

 

2025

 

 

$

 

 

%

 

Consulting and Treatment

 

$

114,587

 

 

$

118,804

 

 

$

(4,217

)

 

 

(3.5

)%

Measurement and Analysis

 

 

53,931

 

 

 

59,030

 

 

 

(5,099

)

 

 

(8.6

)

Total Reportable Segments

 

$

168,518

 

 

$

177,834

 

 

$

(9,316

)

 

 

(5.2

)%

Consulting and Treatment segment revenues for the three months ended March 31, 2026 decreased compared to the three months ended March 31, 2025 primarily as a result of a decrease in revenues from environmental emergency responses of $5.8 million and a $1.0 million decrease in revenues from exited European operations, which were exited in the fourth quarter of 2025, partially offset by organic growth of $2.5 million. Organic growth was primarily driven by growth within our non-response consulting services in the United States, Canada and Australia.

Measurement and Analysis segment revenues for the three months ended March 31, 2026 decreased compared to the three months ended March 31, 2025 primarily due to the impact of severe weather conditions in January and February 2026 in the United States, which limited the ability for field teams in certain regions to get on site and disrupted sample deliveries to our labs.

29


 

Segment Adjusted EBITDA

 

 

Three Months Ended March 31,

 

 

Change

 

(in thousands, except %)

 

2026

 

 

2025

 

 

$

 

 

Margin %

 

Consulting and Treatment

 

$

20,133

 

 

$

16,499

 

 

$

3,634

 

 

 

3.7

%

Measurement and Analysis

 

 

9,937

 

 

 

13,773

 

 

 

(3,836

)

 

 

(4.9

)

Total Reportable Segments

 

$

30,070

 

 

$

30,272

 

 

$

(202

)

 

 

0.8

%

Corporate and Other

 

$

(12,247

)

 

$

(11,242

)

 

$

(1,005

)

 

 

 

Consulting and Treatment Segment Adjusted EBITDA for the three months ended March 31, 2026 increased compared to the three months ended March 31, 2025 primarily as a result of favorable project mix, improved operational cost management in the current year, and losses in the prior year period related to our renewables business, that did not recur in the current year period, partially offset by lower revenues. Segment Adjusted EBITDA margin increased to 17.6% for the three months ended March 31, 2026 from 13.9% in the prior year period due to project mix and improved operational efficiency in the current year, and losses in the prior year period related to our renewables business.

Measurement and Analysis Segment Adjusted EBITDA for the three months ended March 31, 2026 decreased compared to the three months ended March 31, 2025 as a result of lower revenues primarily due to severe weather-related disruptions and project mix. Segment Adjusted EBITDA margin for the three months ended March 31, 2026 decreased to 18.4% for the three months ended March 31, 2026 from 23.3% in the prior year period, driven by project mix and temporarily lower operating leverage resulting from lower revenues in the current year.

Corporate and other costs for the three months ended March 31, 2026 when compared to the three months ended March 31, 2025 increased primarily due to investments in IT infrastructure, software and marketing.

Liquidity and Capital Resources

Liquidity describes the ability of a company to generate sufficient cash flows to meet the cash requirements of its business operations, including working capital needs, debt service, acquisitions, other commitments and contractual obligations. We consider liquidity in terms of cash flows from operations and other sources, including availability under our 2025 Credit Facility, and their sufficiency to fund our operating and investing activities.

Our principal sources of liquidity have been cash generated by operating activities, borrowings under our senior secured credit facilities, other borrowing arrangements, and proceeds from the issuance of common stock. Historically, we have financed our operations and acquisitions from a combination of cash generated from operations, periodic borrowings under senior secured credit facilities, and proceeds from the issuance of common and preferred stock. Our primary cash needs are for day to day operations, to fund working capital requirements, to fund our acquisition strategy and any related cash earn-out obligations, to pay interest and principal on our indebtedness and to make capital expenditures. Historically, our cash needs also included the payment of dividends on our Series A-2 preferred stock. Additionally, in connection with certain acquisitions, we agree to earn-out provisions and other purchase price adjustments that may require future payments. We may make up to $9.6 million in aggregate earn-out payments between the years 2026 and 2027 in connection with certain of our acquisitions of which up to $5.1 million may be paid only in cash, up to $2.8 million may be paid only in common stock and up to $1.7 million may be paid in cash or, at our option, in common stock. See Note 7 to our unaudited condensed consolidated financial statements included in Part 1, Item 1. “Financial Statements.” As of March 31, 2026, we had $178.4 million available under the 2025 Credit Facility (after giving effect to any outstanding letters of credit, and subject to borrowing base limitations), and $10.0 million of cash on hand. In April and July 2025, we redeemed the remaining $122.2 million in aggregate stated value of the outstanding Series A-2 preferred stock using cash and borrowings under our revolving line of credit.

We expect to continue to fund our liquidity requirements, including any cash earn-out payments that may be required in connection with acquisitions, through cash generated from operations and borrowings under our 2025 Credit Facility. We believe these sources will be sufficient to fund our cash needs in the short-term and long-term.

Cash Flows

The following table summarizes our cash flows for the periods presented:

 

 

Three Months Ended March 31,

 

(in thousands)

 

2026

 

 

2025

 

Net cash provided by (used in):

 

 

 

 

 

 

Operating activities

 

$

(11,637

)

 

$

5,504

 

Investing activities

 

 

(5,525

)

 

 

(3,705

)

Financing activities

 

 

15,942

 

 

 

15,962

 

Change in cash, cash equivalents and restricted cash

 

$

(1,220

)

 

$

17,761

 

 

30


 

Operating Activities

Cash flows from operating activities can fluctuate from period-to-period as earnings, working capital needs and the timing of payments for contingent consideration, taxes, bonus payments and other operating items impact reported cash flows.

For the three months ended March 31, 2026, net cash used in operating activities was $11.6 million compared to net cash provided by operating activities of $5.5 million for the three months ended March 31, 2025. The period-over-period decrease of $17.1 million was primarily due to an increase in working capital of $16.3 million.

Working capital (which excludes contingent consideration payments and changes in right-of-use assets) increased by $16.3 million in the three months ended March 31, 2026, primarily due to higher payments of accrued annual bonus in the current year period versus the prior year period of $16.0 million as a result of outperformance in 2025, and a $15.7 million decrease in accounts payable and other accrued liabilities due to the timing of payments, partially offset by a decrease in accounts receivable of $32.5 million due to a decrease in revenue and improved collections.

Working capital increased by $9.4 million in the three months ended March 31, 2025, primarily due to a decrease in accrued payroll and other benefits of $8.6 million, primarily due to the payment of annual bonuses, and a seasonal decrease in accounts payable and other accrued liabilities of $5.5 million. This increase was partially offset by a decrease in accounts receivable of $10.4 million, driven by seasonally lower quarterly revenues, as well as $5.5 million higher prepaids primarily due to the timing of insurance payments.

Investing Activities

For the three months ended March 31, 2026, net cash used in investing activities was $5.5 million, primarily driven by cash paid for the purchases of property and equipment of $5.7 million.

For the three months ended March 31, 2025, net cash used in investing activities was $3.7 million, driven by cash paid for property and equipment and proprietary software development costs.

Financing Activities

For the three months ended March 31, 2026, net cash provided by financing activities was $15.9 million. Cash provided by financing activities was driven by borrowing under our 2025 Credit Facility of $140.4 million, partially offset by repayments of borrowings of $107.1 million, repurchases of common stock of $10.0 million, and a payment for contingent consideration of $8.0 million.

For the three months ended March 31, 2025, net cash provided by financing activities was $16.0 million. Cash provided by financing activities was driven by borrowing under our 2025 Credit Facility of $306.9 million, partially offset by repayments of borrowings of $286.7 million, a portion of which related to the refinancing of our prior credit facility, dividends on the Series A-2 Preferred Stock of $2.8 million and payment of financing cost of $2.2 million.

Credit Facilities

See Note 12 to our unaudited condensed consolidated financial statements included in Part I, Item 1. “Financial Statements” for details on the 2025 Credit Facility.

Series A-2 Preferred Stock

In April and July 2025, we redeemed the remaining $122.2 million aggregate stated value of the outstanding Series A-2 preferred stock.

See Note 15 to our unaudited condensed consolidated financial statements included in Part I, Item 1. “Financial Statements” for details on the Series A-2 Preferred Stock.

Stock Repurchase Program

On May 6, 2025, the Board of Directors approved a stock repurchase program of up to $40.0 million. The repurchase program does not have a set expiration date. During the three months ended March 31, 2026 the Company repurchased 376,313 shares of its common stock for approximately $10.0 million. As of March 31, 2026, approximately $30.0 million of the authorized capacity under the repurchase program remains available for future repurchases.

See Note 16 to our unaudited condensed consolidated financial statements included in Part I, Item 1. “Financial Statements” for details on the stock repurchase program.

31


 

Critical Accounting Policies and Estimates

Our 2025 Form 10-K includes a summary of the critical accounting policies and estimates we believe are the most important to aid in understanding our financial results. There have been no material changes to those critical accounting policies and estimates as disclosed therein, other than as described in Note 2 to our unaudited condensed consolidated financial statements included in Part I, Item 1. “Financial Statements.”

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

Interest Rate Risk

We have market risk exposure arising from changes in interest rates on our credit facility, which bears interest at rates that are benchmarked subject to the Company’s leverage ratio and SOFR. Based on our overall interest rate exposure to variable rate debt outstanding as of March 31, 2026, which factors in our interest rate swaps on $200.0 million of debt, a 1.0% increase or decrease in interest rates on the term loan, aircraft loan, and revolving line of credit would impact our annual loss before income taxes by approximately $1.2 million.

Inflation Risk

In the three months ended March 31, 2026, and year ended December 31, 2025, we experienced, and continue to experience, modestly higher labor costs as a result of inflation. We believe we have successfully raised prices in businesses with short term contracts to offset these inflationary effects. We also have and are continuing to raise prices on medium term (one to four quarter) contracts as these contracts are renewed or new contracts are won, and as a result have been able to offset much of the impact of inflation to date. We expect to continue to raise prices if direct costs continue to increase, and as a result, we do not believe over a longer period of time that inflation will have a material effect on our business, financial condition or results of operations. If our costs were to become subject to additional and unanticipated significant sustained inflationary pressures, we may not be able to fully offset such higher costs through price increases. Our inability or failure to do so could adversely affect our business, financial condition and results of operations.

Foreign Exchange Risk

Foreign exchange risk exposure arises because we sell our services in Canada and Australia. Our exposure to this risk increased significantly due to our acquisitions of Paragon and Matrix in Canada and EPIC in Australia. Revenues in certain foreign countries as well as certain expenses related to those revenues are transacted in currencies other than the U.S. dollar. As such, our future operating results are exposed to changes in exchange rates. When the U.S. dollar weakens against foreign currencies, the dollar value of revenues denominated in foreign currencies increases. When the U.S. dollar strengthens, the opposite situation occurs. Additionally, previously invoiced amounts can be positively or negatively affected by changes in exchange rates in the course of collection. A 1.0% increase or decrease in the U.S. dollar exchange rate would impact revenues by approximately $1.7 million and would have a negligible impact on annual net loss.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

As required by Rule 13a-15(b) under the Exchange Act, our management, including our Chief Executive Officer and Chief Financial Officer, carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act), as of March 31, 2026, the end of the period covered by this Quarterly Report on Form 10-Q. Based on the foregoing, our Chief Executive Officer and Chief Financial Officer concluded that, as of March 31, 2026, the end of the period covered by this Quarterly Report on Form 10-Q, our disclosure controls and procedures were effective at the reasonable assurance level.

Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) that occurred during the quarter ended March 31, 2026, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Limitations on Effectiveness of Controls

Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls and procedures or our system of internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well designed or operated, can provide only reasonable, but not absolute, assurance that the objectives of the system of internal control are met. The design of our control system reflects the fact that there are resource constraints, and that the benefits of such control system must be considered relative to their costs. Further, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control failures and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the intentional acts of individuals, by collusion of two or more people, or by management override of the controls. The design of

32


 

any system of controls is also based in part on certain assumptions about the likelihood of future events, and there can be no assurance that the design of any particular control will always succeed in achieving its objective under all potential future conditions.

33


 

PART II—OTHER INFORMATION

From time to time, we are subject to various legal proceedings that arise in the normal course of our business activities, including those involving labor and employment, anti-discrimination, commercial disputes and other matters. We are not a party to any litigation the outcome of which, if determined adversely to us, would individually or in the aggregate be reasonably expected to have a material adverse effect on our results of operations or financial position. Regardless of outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.

Item 1A. Risk Factors.

Except as set forth below, there have been no material changes to our risk factors from the risk factors disclosed in our 2025 Form 10-K. The risks described in our 2025 Form 10-K, in addition to the other information set forth in this Quarterly Report on Form 10-Q, are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.

We may not be successful in promoting and further developing our new brand, which could adversely affect our business.

We have a limited operating history as a company and have recently changed the Company's name and rebranded all of our businesses under one new brand – Onterris. As a result, the Onterris brand is not fully established. Our industry is highly fragmented and we believe that our future success depends in part on our ability integrate our legacy brands and diverse range of environmental services that we provide under the Onterris brand. Developing awareness and strengthening our brand has required and will continue to require significant time, expense and the attention of management, and any success will depend largely on our marketing efforts and ability to provide our clients with high-quality services. We may lose customers if they do not respond favorably to the new brand or fail to recognize the new brand as a continuation of our prior business. Similarly, the rebranding may also affect our ability to recruit qualified personnel who may not be familiar with the Onterris name. We are also investing more in brand development and brand consolidation and there can be no assurances that this investment will generate additional revenues or business. If we fail to successfully maintain and continue to grow our brand through promotion and other efforts, incur excessive unanticipated expenses in attempting to promote and maintain our brands, or lose clients as a result, our business, financial condition and results of operations may be adversely affected.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Share repurchase activity during the three months ended March 31, 2026 was as follows:

Period

 

Total Number of Shares Purchased

 

 

Average Price Paid Per Share

 

 

Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs

 

 

Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs (in thousands)(1)

 

January 1, 2026 - January 31, 2026

 

 

 

 

$

 

 

 

 

 

$

40,000

 

February 1, 2026 - February 28, 2026

 

 

 

 

$

 

 

 

 

 

$

40,000

 

March 1, 2026 - March 31, 2026

 

 

376,313

 

 

$

26.57

 

 

 

376,313

 

 

$

30,001

 

Total

 

 

376,313

 

 

 

 

 

 

376,313

 

 

 

 

 

(1) On May 7, 2025, the Company announced a stock repurchase program of up to $40.0 million. The repurchase program does not have a set expiration date.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

None.

34


 

Item 6. Exhibits.

 

Exhibit

Number

Description

 

 

 

3.1

 

Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Montrose Environmental Group, Inc., filed April 17, 2026.(a)

 

 

 

3.2

 

Amended and Restated Bylaws of Onterris, Inc.(a)

 

 

 

10.1*

 

Onterris, Inc. Amended and Restated 2017 Stock Incentive Plan.

 

 

 

21.1*^

 

Subsidiaries of the Registrant.

 

 

 

31.1*

Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

31.2*

Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

32.1**

Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

32.2**

Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

101.INS*

Inline XBRL Instance Document

 

 

 

101.SCH*

 

Inline XBRL Taxonomy Extension Schema Document

 

 

 

104*

 

Cover Page Interactive Data File – The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 is formatted in Inline XBRL (included as Exhibit 101)

 

* Filed herewith.

** Exhibit is furnished and shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

^ Exhibit is being refiled to reflect the Company's current subsidiaries and to update the names of certain subsidiaries that were renamed in connection with the Company’s name change to Onterris, Inc.

(a) Previously filed on April 21, 2026 as an exhibit to the Company’s Current Report on Form 8-K and incorporated herein by reference.

35


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Onterris, Inc.

Date: May 7, 2026

By:

/s/ Allan Dicks

Allan Dicks

Chief Financial Officer

 

36